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ABSTRACT 
The aim of this study was to review the clinical and histological 
features and risk factors of hepatocellular carcinoma in Sudanese 
patients.  It is conducted at Ibn Sina Specialized Hospital, 
Khartoum, Sudan, in the period from January 2003- December 2004. 
Sixty-three cases were included in the study with 57 histological 
specimens being retrieved and studied morphologically, using H&E 
stain. The WHO morphologic criteria for the diagnosis of 
hepatocellular carcinoma were used. Relevant request forms and 
medical records were used to obtain the clinical and demographic 
data. 
The results obtained showed that the age ranged between 30 
and 97 years. The commonest age group was between 60-69 years. 
Males were 3.8 more times than females. The majority (52%) was 
farmers and 50% were from the Western region. 
The most common histological pattern was the compact 
subtype (42%) and half of the tumors were of poor differentiation. 
Most of the tumors were either solitary (56.7) or multinodular 
(36.6). 
 V 
 
Alcohol and hepatitis B were the etiological factors in 47 and 
41% of the cases analyzed respectively. HCV was positive in 19%. 
Ethnic variation was evident in HCC. The South showed the 
least incidence (3.7%), whereas the Western region constituted 50% 
of the cases in spite of similar environmental conditions. 
No patient presented with a small tumor size (less than 5 cm) 
which indicates late presentation and poor prognosis. 
The study concluded that hepatocellular carcinoma affects 
males more often than females and hepatitis B virus infection and 
alcohol are the main etiological factors in the studied group. Most of 
the patients presented late with big tumors. The compact subtype is 
the commonest pattern encountered. 
Finally the recommendations included introduction of HBV 
vaccine in infancy, screening for HCV in blood banks, focusing on 
high risk groups, establishing a common histological criteria and 
better keeping of records. 
HCC remains a prevalent tumor in Sudan in spite of possible 
preventive measures. 
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  ﺍﻷﻁﺭﻭﺤﺔ ﻤﺴﺘﺨﻠﺹ 
  
ﻟﺘﺤﺩﻴﺩ ﺍﻷﻨﻤﺎﻁ ﺍﻟﻨﺴﻴﺠﻴﺔ ﻟﻭﺭﻡ ﺍﻟﻜﺒﺩ ﺍﻟﺴﺭﻁﺎﻨﻲ ﻭﺍﻟﻌﻭﺍﻤل ﺍﻟﻤﺅﺩﻴﺔ ﺃﺠـﺭﻴﺕ ﻫﺫﻩ ﺍﻟﺩﺭﺍﺴﺔ 
 – 3002ﻓﻰ ﻤﺴﺘﺸﻔﻰ ﺇﺒﻥ ﺴﻴﻨﺎ ﺍﻟﺘﺨﺼﺼﻲ ﻤﺎ ﺒﻴﻥ ﻴﻨﺎﻴﺭ ﻭﻗﺩ ﺃﺠﺭﻴﺕ   . ﻟﻺﺼﺎﺒﺔ ﺒﻪ ﻓﻰ ﺍﻟﺴﻭﺩﺍﻥ
   .ﻡ4002ﺩﻴﺴﻤﺒﺭ 
ﺒﺔ ﺍﻟﺫﻜﻭﺭ ﻨﺴ.  ﺴﻨﺔ79 ﻭﺍﻟـ03 ﻤﺭﻴﻀﺎﹰ ﺘﺭﺍﻭﺤﺕ ﺃﻋﻤﺎﺭﻫﻡ ﻤﻥ ﺴﻥ 36ﺸﻤﻠﺕ ﺍﻟﺩﺭﺍﺴﺔ 
   . 8.3 : 1ﻟﻺﻨﺎﺙ 
ﻨﺼﻑ ﺍﻟﺤﺎﻻﺕ ﻨﻤﺕ ﻓﻰ ﻏﺭﺏ . ﻜﺎﻨﺕ ﺍﻟﻤﺠﻤﻭﻋﺔ ﺍﻟﻌﻤﺭﻴﺔ ﺍﻷﻜﺜﺭ ﺸﻴﻭﻋﺎﹰ ﻓﻰ ﺍﻟﻌﻘﺩ ﺍﻟﺴﺎﺒﻊ
  . ﺍﻟﺴﻭﺩﺍﻥ ﻭﻜﺎﻨﻭﺍ ﻴﻤﺘﻬﻨﻭﻥ ﺍﻟﺯﺭﺍﻋﺔ
ﻭﻨﺼﻑ % 24ﻫﻭ ﺍﻷﻜﺜﺭ ﺸﻴﻭﻋﺎﹰ ﺒﻨﺴﺒﺔ )tcapmoC( ﺃﻭﻀﺤﺕ ﺍﻟﺩﺭﺍﺴﺔ ﺃﻥ ﺍﻟﻨﻤﻁ ﺍﻟﻀﺎﻡ 
  . ﺍﻟﻌﻴﻨﺎﺕ ﻜﺎﻨﺕ ﻀﻌﻴﻔﺔ ﺍﻟﺘﻤﻴﺯ
ﻋﻠﻰ ﺍﻟﺘﻭﺍﻟﻰ، ﺒﻴﻨﻤﺎ % 14 ﻭ74ﻹﺼﺎﺒﺔ ﺒﻔﻴﺭﻭﺱ ﺏ ﺍﻟﻜﺒﺩﻱ ﻨﺴﺒﺘﻲ ﻭﺍ ﺘﻌﺎﻁﻰ ﺍﻟﻜﺤﻭل ﻤﺜّل
  . ﻓﻰ ﺍﻟﺤﺎﻻﺕ ﺍﻟﻤﺸﺨﺼﺔ% 91ﻜﺎﻨﺕ ﻨﺴﺒﺔ ﺍﻹﺼﺎﺒﺔ ﺒﻔﻴﺭﻭﺱ ﺴﻰ ﺍﻟﻜﺒﺩﻯ 
ﻭﻴﻘﺎﺒﻠﻪ ﺃﻋﻠﻰ ﻨﺴﺒﺔ ﺇﺼﺎﺒﺎﺕ ﻓﻰ ﺍﻟﻐﺭﺏ % 7.3ﻤﺜّل ﺠﻨﻭﺏ ﺍﻟﺴﻭﺩﺍﻥ ﺃﻗل ﻨﺴﺒﺔ ﻓﻰ ﺍﻹﺼﺎﺒﺔ 
ﺩﻟل ﻋﻠﻰ ﻭﺠﻭﺩ ﺘﻔﺎﻭﺕ ﻫﺫﺍ ﺒﺎﻟﺭﻏﻡ ﻤﻥ ﺘﻘﺎﺭﺏ ﺍﻟﻅﺭﻭﻑ ﺍﻟﺒﻴﺌﻴﺔ ﻭﺍﻟﻌﻭﺍﻤل ﺍﻟﻤﺴﺎﻋﺩﺓ ﻤﻤﺎ ﻴ%. 95
  . ﺠﻴﻨﻲ ﺃﻭ ﻭﺠﻭﺩ ﻋﻭﺍﻤل ﺤﻤﺎﻴﺔ ﺃﺨﺭﻯ
 ﺴﻨﺘﻤﺘﺭ ﻓﻰ ﻜل ﺍﻟﺤﺎﻻﺕ 5ﺤﺠﻡ ﺍﻟﻭﺭﻡ ﻟﺩﻯ ﺍﻟﻤﺭﻀﻰ ﺍﻟﻤﺸﺨﺼﻴﻥ ﻜﺎﻨﺕ ﻗﻴﻤﺘﻪ ﺃﻋﻠﻰ ﻤﻥ 
  . ﻤﻤﺎ ﻴﺩل ﻋﻠﻰ ﺘﺄﺨﺭ ﻓﻰ ﺍﻟﺘﺸﺨﻴﺹ
  . ﻴﺒﻘﻰ ﺴﺭﻁﺎﻥ ﺍﻟﻜﺒﺩ ﻤﻥ ﺍﻷﻭﺭﺍﻡ ﺍﻟﻤﻨﺘﺸﺭﺓ ﻭﺍﻟﻔﺘﺎﻜﺔ ﻓﻰ ﺍﻟﺴﻭﺩﺍﻥ ﺭﻏﻡ ﺘﻭﺍﻓﺭ ﺴﺒل ﺍﻟﻭﻗﺎﻴﺔ ﻤﻨﻪ
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 1 
1. INTRODUCTION AND LITERATURE  
 
Hepatocellular carcinoma (HCC) is one of the most common 
malignant tumors in sub-Saharan Africa. It has got a high mortality 
rate with 5- year survival rate less than 5%. However most if not all of 
its well known causal factors are preventable either through 
immunization or avoidance. 
Identifying high risk groups helps early diagnosis and direct 
implementation of preventive measures. Also early detection of the 
tumor greatly affects survival. 
There is a need to study the histological patterns of HCC 
because little information about the subject is known locally despite 
the fact that it is a common malignancy in Sudan. 
A clue to the common morphological criteria can be obtained 
for further comparisons. 
HCC affects a population at its productive age- groups in areas 
endemic for hepatitis B virus (HBV) and thus have an impact on 
economical growth.  
 
 2 
Most important is that it is an environmental disease 
evidenced by its lower incidence in developed countries and hence it 
is potentially preventable. 
1.1. Definition: 
Hepatocellular carcinoma (HCC) is a malignant tumor arising 
from hepatocytes. It accounts for 70-90% of all primary liver cancer. 
Exceptions are areas where liver flukes are endemic where 
cholangiocarcinoma predominates.  
Most common etiological factors are viral infections (HBV, 
HCV), dietary aflatoxin B1 ingestion and chronic alcohol abuse.(1) 
1.2. Epidemiology: 
A. Internationally: 
   Hepatocellular carcinoma (HCC) is one of the commonest 
internal malignancies worlds wide. Most authors consider it among 
the ten most common cancers in the world. HCC is the seventh most 
prevalent cancer in men and ninth in women.   It is one of the most 
deadly tumors with 5-year mortality rate more than 95% in untreated 
cases.(1,2)  
 3 
The global number of new cases was estimated to be about 
437, 000 new cases in 1990, accounting for 7.4% (males) and 3.2% 
(females) of all malignancies excluding skin cancer.(1) 
HCC has two rough patterns, in sub-Saharan Africa and               
S.E. Asia, especially Taiwan and China it is the commonest 
malignancy. In the western hemisphere HCC is generally seen as a 
rare cancer, affecting those with pre-existing liver disease. This 
reflects the different exposure to risk factors especially viral causes.(3) 
It accounts for 20% to 40% of cancer deaths in regions of high 
incidence.(4,5)  HCC affects males more than females, approximately in 
the ratios of 3:1 -6:1. In high prevalence areas, it is generally more than 
3.(1) It can reach 8:1 in regions with high incidence.(6)  
Significant variations in liver cancer incidence among different 
ethnic groups living in the same geographical area and among 
migrants of the same ethnic groups living in different areas have been 
extensively described. The variability of liver cancer incidence rates 
between countries and within countries, strongly suggests differences 
in exposure to risk factors.(7) It is postulated that the male hormonal 
milieu has a permissive role in hepatocarcinogensis. (8) 
 4 
Age standardized incidence rate (ASR) of more than 20.1 per 
100, 000 for males is seen in sub-Saharan Africa, South Africa, East 
Asia and Melanesia. Low risk areas (ASR < 3.2) are North America 
and South America.(1,9)  Thus developing countries carry more than 
80% of expected global cases.(9) 
Regional age specific incidence differs significantly. In areas 
with high incidence of HCC related Hepatitis B Virus (HBV), there is 
steep increase in the age 20-34, levels off at 40. In Japan (high risk 
area) and Italy (low risk area), where more than 70% are HCV- related  
HCC, show relatively higher age rates at 55-59 due to chronicity of the 
virus.(1,9) A changing prevalence of risk factors among population as 
well as changes in diagnostic techniques affected disease incidence, in 
Japan and Italy it is increasing.(1) 
Incidence of HCC is increasing in some areas, with about 
500,000 –one million new cases yearly. More than half the cases are in 
China, and in sub Saharan Africa are high.(6) 
In Saudi Arabia, HCC is the most common tumor seen in 
Saudi males; age at presentation is the sixth decade, male: female ratio 
is 4:1. HB-sAg was found in 65% of cases.(10)  
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  In Nigeria the estimated rate in 1970 was 6.6/100,000. HBV is 
the commonest predisposing factor in developing countries.(11) 
The prevalence of HBV infection in adult population of 
Senegal is up 85%. Young children are victims of hepatitis B which is 
endemic in Senegal. Indeed, the risk of becoming chronic carrier 
which can further lead to HCC is related to the age at which the 
infection had been contracted. HBV markers were detected in 59.38% 
of sera of children. The high prevalence of this infection in children 
explains the high incidence of HCC. (12) 
The highest reported incidence of HCC is in Mozambique.(8)    
In a Mozambique tribe called Shanganns, 328 males with primary 
HCC, were studied. Mean age was 33.4 and HBs-Ag was positive in 
60% of cases.(13) 
HCC is the commonest malignancy in Rhodesian blacks, 
which results in high index of suspicion. Alcoholism is the main cause 
in the group studied (28 cases). No one was found to be HBV 
positive.(14) 
In USA, a low incidence area, most cases are seen in males of 
Chinese descend. This is due to high prevalence of HBV in this race. 
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Black men in USA are more than twice as likely to get the disease as 
their white counterparts, with 6.1cases reported per 100,000 black 
men, there were 2.8 cases among white men. The most common 
causes are alcoholic cirrhosis, steroid use, and haemochromatosis in 
general.(15) 
Japan shows the highest incidence in industrialized countries 
(4-5%). HCC is the second most common cause of death among men 
from cancer in Japan. About 90% of cases are due to HBV and HCV. 
Illegal amphatemine drug abuse was endemic in Japan after 
Second World War, leading to spread mainly of HCV. The annual 
death rate of 32000 is expected to rise over the next 10 years. Men tend 
to get the disease more than women.(16)  
Most patients die within one year of diagnosis. The average 
survival period is 5-9 month. In sub-Saharan Africa the average 
survival is 3 month from diagnosis due to late presentation.(8) 
B. HCC in Sudan: 
HCC is one of the prevalent tumors in this country. According 
to WHO, the regional average value for the prevalence of HCC in 
Sudanese males in 1995 was between 10.8 and 20.9 per 100,000. This 
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puts Sudan in moderately high risk areas for HCC, preceded by that 
of China and other higher risk countries.(1) 
  Sudan cancer registry reflected moderate but substantial 
increase over the periods 1970 to 1974(1.7%) to 3.8% in 1979-1984 for 
both liver and gallbladder tumors. (17) 
Mohamedian studied a hundred HCC cases in 1993. Mean age 
was found to be 51.2 years. Sex (male: female) ratio was 4:1. The 
highest incidence was in the west (36%), followed by the central 
region (17%). In southern region, it was only 2 %. (17) 
All HBV markers were studied in the HCC cases. At least 90% 
have one marker, 60 were positive for HBs-Ag, 63 were positive for 
anti- core and 10 were positive for anti-e. In controls, carrier rate for 
HBs-Ag was 7.4 %. (17) 
Previous studies in Sudan which are done on the relationship 
between viral hepatitis and HCC had all established a very strong 
association with HBV ranging from 38.55 to 67% of HCC cases 
whereas HCV was implicated in 11to 17.3% of cases. (Cited in 17, 18) 
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1.3. Anatomy and Functions of the Liver: 
1.3.1. Anatomy and Histology of the liver:  
The liver is the largest internal organ in the body. It is divided 
into right, left and caudate lobes. Divisions of the hepatic vein further 
divide the liver into 8 segments. Each segment receives its own portal 
pedicle, permitting segment resection at surgery. 
The blood supply to the liver (25% of the cardiac output) is via 
hepatic artery (25%) and portal vein (75%). The blood from the 
venules is distributed to the segments and passes into the sinusoids 
via portal tracts. Blood leaves through the three branches of the portal 
tracts to drain into the inferior vena cave. The caudate lobe has an 
independent blood supply. Lymph in the perisinosoidal space is 
collected by lymphatics in the portal tracts to drain into the hepatic 
ducts.(19) 
The liver exhibits repeating hexagonal units arranged around a 
central vein called liver lobules. Plates of liver cells and sinusoids 
radiate from the central vein towards the periphery. Here the 
connective tissue forms portal triads or portal areas where branches of 
hepatic artery, hepatic portal veins, and bile duct can be seen. Venous 
 9 
and arterial blood first mix in the liver sinusoids as it flows towards 
the central vein. The cell thickness between the sinusoids is one to two 
cells thick.(20) 
The functional unit of the liver is the acinus. It is divided into 3 
zones separated by sinusoids, which are dilated tortuous blood 
channels. The sinusoids lack a basement membrane and are 
surrounded by specialized fenestrated endothelial cells and Küpffer 
cells. The subendothelial space is called the space of Disse, which 
contains a matrix of basement membrane constituents, and satellite 
cells, which regulate sinusoidal blood flow. 
Endothelin and nitric oxide modulate stellate cell contractility. 
After activation they produce collagen type 4. The bile canaliculi form 
a network between the hepatocytes. They join to form thin bile 
ductules to form the bile ducts in the portal tracts. The left and right 
bile ducts join at the porta hepatis to form the common bile duct. The 
gallbladder is connected to the hepatic duct via the cystic duct.(19) 
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1.3.2. Functions of the liver: 
Protein metabolism: 
The liver is the principal site of synthesis of all circulating 
proteins apart from gamma globulins. Plasma contains 6-8 gm/L of 
protein mainly in the form of albumin, globulin and fibrinogen. 
Transport and carrier proteins, such as transferrin, caeurloplasmin, 
acute phase proteins, Alfa-fetoprotein and Alfa-1 antitrypsin are all 
synthesized in the liver. All coagulation factors, except factor 8 and 
complement system are also included. 
Degradation of nitrogen and excretion of amino acids is via 
transamination and oxidative deamination to produce ammonia. 
Carbohydrate metabolism:- 
Glucose homeostasis and the maintenance of blood sugar is a 
major function of the liver. The liver stores approximately 80 grams of 
glycogen. In fasting state, blood glucose level is either maintained by 
release of stores or by newly synthesized glucose (gluconeogensis). 
Lipid metabolism:- 
Fats are insoluble in water and are transported in plasma as 
protein-lipid complexes. The liver synthesizes lipoproteins. It 
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synthesizes VLDL and HDL. HDL are the substrate for LCAT which 
catalysis the conversion of free cholesterol esters. Hepatic lipase 
removes triglycerides from IDL to LDL. 
Bile acid secretion:- 
Bile acid acts as detergent, which renders lipid more soluble, 
and hence facilitates absorption in the intestine. It consists of water, 
electrolytes, bile acids, cholesterol, phospholipids and conjugated 
bilirubin. Two processes are involved in bile secretion: salt dependent 
and salt independent processes, each constituting for 230ml/day. 
About 150ml daily is secreted by bile ductules. Flow of bile to the 
duodenum is stimulated by cholycystokinin. About 600 ml is 
excreted. In the fasting state half goes to duodenum and the other half 
is stored in the gallbladder via the cystic duct. 
Hormone and drug metabolism:- 
The liver is the primary target for many hormones (e.g. 
insulin). The liver catabolizes hormones as insulin, glycogen, 
estrogens, growth hormone, glucocorticoids, and parathyroid 
hormone. 
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Drugs are also metabolized by the liver, and rendered soluble 
to be excreted in bile or urine. Alcohol is oxidized to CO2, H2O, and 
fatty acids. 
Immunological function:- 
The liver acts as a sieve for antigens carried to it via the portal 
tracts from the gastrointestinal tract. Küpffer cells represent the first 
line of defense. They secrete IL1, TNF, collangenases, and lysosmal 
hydrolysases. Following stimulation of Küpffer cells by endotoxins, 
the Küpffer cells release cytokines which also play a key role in 
parenychmal damage. The stimulated hepatocytes themselves express 
adhesion molecules and release IL-8 which is a potent neutrophil 
chemo attractant. Homing of mucosal lymphocytes has been 
proposed; they release cytokines, all damaging the function of the 
hepatocyte leading to cholestasis and also induce apoptosis.      
 Bilirubin and bile acid metabolism:- 
  Bile acid: is synthesized in hepatocytes from cholesterol.  
They are conjugated with glycine and taurine at ratio 3:1 then they are  
converted by bacteria into secondary bile acids. They act as 
detergents; their main function is lipid solubilization.  
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Bilirubin metabolism:- 
  Bilirubin is produced mainly from breakdown of 
haemoglobin in the reticuloendothelail system. It is insoluble and is 
carried to the liver bound to albumin. Biliverdin is conjugated with 
glucronic acid and excreted in bile. The conjugated bilirubn is actively 
secreted in bile to the intestine. Urobilinogen bound to albumin enters 
the circulation and is excreted in the urine as urobilinogen.(19) 
1.4. Liver Neoplasms 
Liver growths comprise both benign proliferations, some with 
a malignant potential and malignant tumors arising from both 
epithelium and stroma. Knowledge of other primary liver and benign 
proliferations is mandatory for the correct diagnosis of hepatocellular 
carcinoma. 
1.4.1. Benign Proliferations and Tumours of the Liver: 
There are several types of benign tumors or tumor-like 
conditions that occur in the liver. Years ago, these were usually 
incidental findings at autopsy. Now, CT, and MRI imaging techniques 
routinely find these masses. As such, these masses require 
differentiation from malignant tumors.  
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The following are considered benign growths of the liver:- 
• Adenomatous hyperplasia (dysplastic nodules): 
These are hyperplastic nodules most of which are less than 1.5 
cm in diameter. The nodules lack features of definite malignancy. 
Dysplastic nodules have been observed in explants HCC livers and 
cirrhotic livers. Macroscopically; it mimics small well differentiated 
HCC with distinct margins. Microscopically; they are characterized by 
a moderate increase in cell density with slight irregular trabrecular 
pattern.(1, 21)  
There are many portal tracts but no invasion. Most of them 
will proceed to HCC and are considered as precancerous. Other terms 
include macro regenerative nodules, hyperplasic and borderline. To 
differentiate dysplastic nodules from HCC, the latter has a nuclear 
density of 2 compared with dysplastic nodules which have a normal 
nuclear density (performed by gestalt.).(21) 
Focal liver cell dysplasia is divided into: 
1. Large cell dysplasia: there is cellular enlargement, nuclear 
pleomorphism and multinucleation. It is found in 65% of patients 
with cirrhosis and HCC compared with 7% of patients with 
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cirrhosis alone. It has a great association with HB-sAg. The 
presence of large cell dysplasia identifies patients in great risk to 
develop HCC.(1, 21) 
2.  Small cell dysplasia; the nuclear cytoplasmic ratio is increased. It 
is considered to be the precancerous lesion leading to HCC. (1,21) 
3. Cavernous hemangiomas:  
It is the most common benign tumour. Predominately, it is 
seen in females less than 40 years of age. Usually it is identified as 
discrete red to dark blue nodules located beneath the capsular surface. 
It is composed of endothelial-lined blood-filled spaces. (22) 
Nodular Hyperplasia: 
Nodular hyperplasia is divided into: 
1. Focal Nodular Hyperplasia (FNH): FNH appears as yellow-tan, 
discrete but poorly encapsulated nodules which are up to several 
centimetres in diameter. On section, there is usually a central scar 
with fibrous strands radiating to the periphery. Within these 
strands are numerous bile ducts with a dense lymphocytic 
infiltrate. The remaining cells making up the hyperplastic nodules 
are hepatocytes, which may be lipid, or glycogen-rich or otherwise 
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normal. It is thought to be associated with arteriovenous 
malformation. Usually found more often in women and there is a 
reported, but controversial association with oral contraceptives or 
other steroid use. FNH should be differentiated from cirrhotic 
nodules. Ductular component should be present for diagnosis.  
2. Nodular Regenerative Hyperplasia: Affects the entire liver with 
roughly spherical nodules, in the absence of fibrosis the 
architecture of the liver is abnormal and this is associated with 
portal hypertension similar to FNH, the underlying causes are 
thought to be vascular (i.e. vasculitis).(21) 
Liver cell Adenoma: 
It is yellow-tan, discrete but poorly encapsulated nodule up to 
several centimeters in diameter. Microscopically; it is composed 
mostly of normal-appearing hepatocytes, which occasionally vary in 
both cell and nuclear size. Of note is the presence of abnormal, dilated 
sinusoids as well as the absence of bile ducts.(1, 21) 
Usually found more often in young women on oral 
contraceptives. Tumor may even regress after cessation of pill use. 
Besides being confused occasionally with HCC, sub capsular 
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adenomas may rupture, especially during pregnancy, causing 
massive intraperitoneal hemorrhage. These are not the precursor 
lesions of HCC. Features suggesting HCC include mitosis, high 
nuclear cytoplasmic ratio, and plates more than two cell thick. Besides 
this, there is loss of normal reticulin in HCC. CD34 immunostain 
typically stain with HCC, but only focally if not at all with liver cell 
adenoma.(21,22) 
1.4.2. Primary malignant liver tumors:  
Cholangiocarcinoma:  
It is a cancer which is comprised of malignant bile duct 
epithelium. Virtually it makes up the remainder of primary liver 
cancers. None of the risk factors for the development of HCC apply to 
cholangiocarcinoma. Known risk factors include exposure to 
thorotrast, primary sclerosing cholangitis and invasion of the 
bileducts by liver flukes–opisthorchis sinensis. 
Gross: similar to HCC, but tumour is never bile-stained (bile 
duct epithelium does not synthesize bile). Also there may be a dense 
desmoplasia resulting in a gritty texture. 
Microscopy: usually well differentiated tumours forming 
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glands and tubules. As mentioned earlier, often there is a dense 
desmoplasia. Mucus but not bile may be found in individual cells as 
well as in the Lumina of glands.  
Hepatoblastoma: 
It is also called "Liver cancer of infants". It is the most common 
hepatic tumor of infants. However it is one of the least common 
tumors in infancy (1-5%). It presents with an abdominal mass and 
usually has an elevated AFP (80-90%). 
Angiosarcoma: 
Similar to angiosarcomas found elsewhere. They are highly 
aggressive cancers of endothelial cells that usually kill within one 
year. It is associated with exposure to thorotrast, vinyl chloride and 
arsenic with a long (decades) latency. 
1.4.3. Metastatic tumors:  
  By far the most common cancer found in the liver is a 
metastatic tumor. Any cancer may metastasize to liver, but favoured 
primary sites include breast, lung, and colon. There are usually 
multiple nodules with a tendency towards central ischemic necrosis as 
the implant outgrows its blood supply. Of note is the often-massive 
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involvement of the liver by tumor before any clinical signs are 
noted.(22) 
1.5. Hepatocellular Carcinoma: 
By far it is the commonest primary liver neoplasm accounting 
for 70-90% of cases.(1) 
1.5.1. Macroscopic and microscopic features of hepatocellular carcinoma: 
1.5.1.1. Macroscopic features: 
Macroscopic features of HCC vary depending on the size of 
the tumor, and the presence or absence of liver cirrhosis.(1, 21) Very 
small tumours less than 2 cm usually present as a nodule with a 
distinct fibrous capsule and or fibrous septa are noted. Often they are 
gray white, green or yellow.(21)  
Generally those associated with cirrhosis tend to be expansible 
with intratumoral septa. Those without cirrhosis tend to be massive 
and none capsulated.  
Varying degrees of tumor growth, portal vein thrombosis, and 
intrahepatic metastases modify the tumor gross appearance in 
advanced tumors.(1) 
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There are 5 recognizable growth patterns: 
1- Solitary.  
2- Multifocal: if large nodules are present, it is called Nodular  
3- Diffuse:  if the nodules are small and numerous. 
4- Massive or expanding type; occurs in normal liver, usually 
with satellite nodules.(1, 21, 22)  
5. Pedunculated tumor is occasionally seen in females.(1, 22)   
  The tumor may be green from bile staining. There may be 
massive liver enlargement. 
  Macroscopic portal vein, hepatic vein and bile duct invasion 
are noted in 35%-80%, 20-25%, and 1-7% of cases respectively. 
Involvement of the inferior vena cava, sometimes with extension to 
the right atrium may be found. (21) 
1.5.1.2. Histologic patterns: WHO Classification  
  HCCs vary architecturally and cytologically. The different 
patterns frequently occur in combination. HCC is typically associated 
with little stroma, which accounts for its soft nature. Significant 
fibrosis occurs in about 5% of cases (scirrhous HCC and 
fibrolammelar “FL-HCC”). These patterns are frequently found 
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together in the same tumor. Only FL-HCC appears to have prognostic 
significance. 
Trabecular:  
  This pattern is nearly always present in some part of HCC. It 
appears as a distorted caricature of the normal liver cell plates. The 
trabeculae vary in thickness and are surrounded by sinusoids and a 
variable number of macrophages. The reticulin framework is 
generally absent but rarely can be accentuated.(1) This pattern is the 
most common in well and moderately differentiated tumors. Tumor 
grows in cords of variable thickness. Well-differentiated tumors have 
thin trabecular pattern. Trabeculae become thicker with less 
differentiation. Small HCC <2 cm should be differentiated from 
dysplastic nodules and macroregenerative nodules associated with 
cirrhosis.(1, 21) 
Pseudoglandular: 
This is seen as the dominant pattern in 5-10% of cases, but at 
least can present focally in one third of tumours. The spaces present as 
dilated bile canaliculi. Gland like spaces may be formed by palasading 
of tumour cells around dilated sinusoids. The lumen may contain bile 
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or an oesinophilic hyaline PAS- positive material.(21) 
Glandular pattern is usually admixed with trabecular pattern. 
The glandular structure is made of single layer of tumour cells. The 
glandular structure is smaller in well-differentiated tumors. They 
should be differentiated from metastatic adenocarcinoma to the 
liver.(1) 
Compact: 
This variant is 5-10% of HCCs.(21) Adjacent trabeculae merge to 
form sheets compressing the sinusoids, thus making them 
inconspicuous.(1,21)The cells at the periphery may be columnar. 
Compact tumours should be differentiated from regenerated 
hepatocytes or from large cell carcinoma of extra hepatic origin. This 
may be difficult in small biopsies. (21) 
Scirrhous: 
This uncommon pattern is characterized by marked fibrosis 
along the sinusoidal blood spaces, with variable degree of atrophy of 
tumour trabeculae. It is observed also in small tumours. Similar 
fibrotic changes occur following chemotherapy, radiation or 
transchemoembolization.(1) It is found in less than 1-2% of all HCCs.(21) 
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Fibrolammelar (FL) variant: 
FL-HCC is a distinctive variant with prolonged survival. It 
arises in noncirrhotic livers of young individuals. It accounts for 1-5% 
of all cases. It is quite rare in regions of high incidence of HCC.(1,14,21) 
Des Gamma-carboxyprothrombin is uniformly elevated. Calcification 
is common. The tumor is firm with white or brown tan. They are 
typically large (13 cm); solitary (75%) and well circumscribed. Fibrous 
septa divide the tumor to form a stellate scar.(21, 22)  
The tumor consists of large polygonal cells with abundant 
granular cytoplasm, sharply defined cell borders, and large vesicular 
nucleus with a prominent nucleolus. Sheets of collagen separate the 
hepatocytes. The eosinophilic granularity is due to the presence of 
mitochondria.(1, 21, 22) 
1.5.1.3. Cytological Variants: 
The tumor cells of HCC are usually polygonal and have 
distinct cell membranes, a higher nuclear/cytoplasmic ratio compared 
to normal hepatocytes, and a round nucleus containing a nucleolus, 
coarse chromatin and thick irregular nuclear membrane. Prominent 
nucleoli are common. Intranuclear cytoplasmuc inclusions are a 
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common albeit nonspecific finding in HCC. The following histological 
variants are recognized.(21) 
Pleomorphic (giant cell): 
Tumor giant cells often multinucleated and quite 
hyperchromatic nuclei predominate in this variant, which comprises 
less than 1% of all HCCs. There is marked variation in cellular and 
nuclear shape and size. Generally they lack cohesiveness and do not 
show trabecular pattern. They are common in poorly differentiated 
tumours.(1) 
Clear cell: 
The tumor consists predominantly of cells with clear 
cytoplasm due to the presence of abundant glycogen.(1, 21) It is the 
predominant appearance in 5-16% of cases. However, 20-40% of 
HCCs contains a few clear cells. Differential diagnosis includes 
metastatic renal cell carcinoma of clear cell type.(21) 
Sarcomatoid spindle cell variants: 
  It comprises 1-9 %(21) It may exhibit sarcomatoid component 
characterized by spindle shaped cells. Pleomorphic or osteoclast giant 
cells may be seen. Thereby it overlaps with the giant cell variant.(1)   
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Serum AFP is less compared to the usual HCC.(21) Diagnosis of 
fibrosarcoma, myogenic sarcoma or malignant fibrohistiocytoma is 
suggested.(1, 21) 
In many cases the sarcomata's change is present in part of the 
tumor. Most sarcomas are positive for vimentin or desmin but 
negative for albumin. Some are positive for cytokeratin.(1) 
Fatty change: 
  Diffuse fatty change is most frequent in small early stage 
tumors, less than 2 cm in diameter. Metabolic disorders are suggested 
for the pathogenesis. It is rather infrequent in advanced tumors. (1) 
1.5.1.4. Cytoplasmic Inclusions: 
•  Mallory hyaline bodies: Mallory bodies are intracytoplasmic 
irregular in shape, oesinophilic and PAS negative. They consist of 
aggregated intermediate filaments. They stain positive with 
antiubiquitin. 
•  Granular hyaline bodies: They are small, round, homogenous and 
strongly acidophilic intracytoplasmic bodies. They are PAS positive. 
•  Pale bodies: Pale bodies are intracytoplasmic, round, amorphous 
and lightly oesinophilic granules. They represent amorphous 
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material in cystically dilated endoplasmic reticulum. They show 
distinct immunoreactivity with antifibrinogen. Commonly they are 
seen in FL-variant, but also in common types as sicchrous. 
•  Ground glass inclusions:  Rarely is it observed in tumors of HBs-
Ag positive patients. They are HBV positive hepatocytes entrapped 
in tumor cells.(1,21,22)   
•  Bile: Bile is occasionally observed as bulges in dilated canaliculi or 
pseudoglands. 
1.5.2. Grading and Staging of HCC tumors: 
1.5.2.1. Histological Grading of HCC:  
Well-differentiated (Grades 1&11 of Edmondson and Steiner):  
Thin plates, three or fewer hapatocytes thick, that are typically 
smaller than normal hepatocytes, demonstrate minimal nuclear atypia 
and have a nuclear density greater than twice that of the non-
neoplastic liver. Fatty change and pseudoglandular structures are 
common. This pattern is typical of small <2cm HCC. Clear-cut 
histological distinction from hepatocellular adenoma may not be 
possible.(1, 21) 
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Moderately differentiated (grade II&III Edmondson and Steiner): 
This is typically characterized by a trabecular pattern by which 
tumor cells are arranged in plate more than three cells thick. Tumor 
cells are larger and have more abundant cytoplasm and distinct 
nucleoli. Pseudoglands and bile are usually seen. Tumour giant cells 
may be present.  
Poorly differentiated HCC (Grade IV): 
Tumour cells have larger and more hyperchromatic nuclei and 
are typically arranged in compact solid groups with rare or no 
trabeculae or bile. Pleomorphism may be prominent and spindle cell 
or small cell areas may be seen. It may be difficult to recognize as 
hepatocellular in origin. It is extremely rare in small tumour size 
HCCs.(1, 21) 
Undifferentiated tumour:  
  Rare, accounts for less than 2% of epithelial liver tumors. It is 
Associated with poorer prognosis. (1)  
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1.5.2.2. Pathologic TNM Staging of Primary Hepatic Epithelial 
Malignancies: (21) 
T:   Primary tumour  
T1: Solitary mass without vascular invasion  
T2: Solitary mass with vascular invasion, or multiple tumors not >5 
cm  
T3: Multiple masses >5cm or tumor involving a major branch of the 
portal or hepatic veins.  
T4: Tumor with direct invasion of adjacent organs, other than the 
gall bladder or with perforation of the visceral peritoneum.  
N: Regional lymph nodes  
N0: Negative regional lymph nodes  
N1: Positive regional lymph nodes  
M: Distant metastases  
MX: Cannot be assessed  
M0: No distant metastases  
M1: Distant metastases present  
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Stage groupings:  
Stage  I      : T1 N0 M0 
Stage II     : T2 N0 M0  
Stage IIIa : T3 N0M0  
Stage IIIb : T4 N0 M0  
Stage IIIc : any TNI M0 
Stage IV  : any T any N, M1 
  Researches and studies done on the histological patterns all 
concluded no correlation between the histological subtype and the 
risk factor present whether viral or other cause.(23) 
  The most frequent pattern present in a Saudi study aiming to 
define the histological subtypes and the morphologic criteria of HCC 
specimens (n= 42) found the compact or sinusoidal pattern was the 
most prevalent, being present in the majority of specimens, followed 
by the trabecular and pseudoglndular. Well differentiation carcinoma 
was 58% and moderately differentiated tumor represented 33% and 
poor differentiation grade constituted 8%.  Bile was present in 27% of 
the sections, multinucleated giant cell were noted in 46% of biopsy 
specimens.(10) 
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 In Thailand where HBV is endemic, 180 cases were recruited 
from the archive in Sonklanagarind Hospital, period 1991-1998; the 
reclassified histological patterns were correlated with the microscopic 
features and laboratory data. Males were 147 and HBV was the main 
etiologic factor. The histological subtypes were trabecular 63.3%; 
compact 15.6%; scirrhous 7.8%; pseudo glandular 5%, and 
fibrolammelar 0.6%. (23) There was no correlation between histological 
subtype and clinical findings. Also the same applies between HBV, 
HCV and cirrhotic status. A correlation between AFP and the 
AST/ALT ratio was evident. Ten cases were of good differentiated 
type, 88 were moderate and 51 were poor (n=165). Bile was present in 
115 specimens.(23)  
Other similar studies in Asia showed the trabecular pattern 
ranging from 71.3-43.5%; the compact 23.7-9.9% and the scirrhous 
pattern 7.8-1%. Pseudoglandular represented between 12.5-5.0% and 
fibrolammelar was the least ranging from 1-1.8%, mostly arising in 
non cirrhotic livers.(23) 
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1.6. Risk factors of Hepatocellular carcinoma: 
1.6.1. Cirrhosis: 
Macronodular cirrhosis is the most common predisposing 
factor worldwide. Over 80% of HCC patients will have cirrhosis. (24,25) 
Chronic alcoholism and chronic active hepatitis are common 
causes. Rare cases are associated with haemochromatosis, aflatoxin, 
steroid use,(24,25) alfa-1-antitrypsin deficiency and hereditary 
tyrosinemia(25). HCC is rarely seen with Wilson disease or primary 
sclerosing cholangitis. Recent studies showed that the risk associated 
with primary biliary cirrhosis is comparable to that of other forms of 
cirrhosis. (25) 
1.6.2. Hepatitis B Virus (HBV): 
1.6.2.1. Introduction: 
   HBV is a serious health problem with 2 billion people 
infected worldwide, and 350 million suffering from chronic HBV 
infection. It results in 50000- 1.2 million deaths per year. HCC 
accounts for 320000 deaths per year. 
 In western countries, the disease is rare and acquired 
primarily in adulthood, whereas in Africa and Asia, chronic HBV 
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infection is common and usually acquired perinatally or in childhood. 
HBV is transmitted horizontally by blood and blood products 
and sexual transmission. It is also transmitted vertically from mother 
to infant in the perinatal period, which is the major mode of 
transmission in regions where HBV is endemic. (2, 26) 
Most of HCV infection occurs in adult life (25%) of cases. Thus 
HCC in younger individuals (fewer than 50 years of ages) is 
attributable to HBV in more than 75% of cases. (2) 
Bedbugs of the species Cimex hemipterus (F) were considered 
as vectors transmitting HBV in one study in Senegal, West Africa. 
HBs-Ag was detected in unengorged nymph and adult bedbugs in 3 
collections.(27)  
1.6.2.2. Carcinogenesis: 
Epidemiological studies have shown convincingly that HCC is 
closely associated with chronic HBV infection.(8, 28)  
HBV is a double stranded DNA virus in the hepadnaviridae 
family. The HBV genome has four genes: pol, env, pre-core and 
protein x.(8, 26) 
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The function of protein x is not clear but it may be involved in 
the activation of host cell genes and the development of cancer.(8, 26, 29) 
It is now well established that the majority of HCCs related to HBV 
infection contain HBV DNA segment integrated into the hepatocyte 
chromosomal DNA leading to chromosomal DNA derangements as 
evidenced by transaction experiment.(8) 
The incidence of HCC was as high as 85% in transgenic mice. It 
was also found that the structure of the x genome is modified in the 
majority of tumorous livers. All of theses indicate a multifactorial and 
multistep development of HCC.(29) 
A group of 2681 male and 977 females' blood donors in 
England and Wales, found to be HBs-Ag positive, were followed up 
from recruitment and their cause specific mortality was analyzed and 
compared to the general population.  It was found that 17.4% of the 
420 deaths were due to liver disease and or HCC. So it was concluded 
that HBs-Ag carries a significant risk factor for both liver disease and 
HCC mortality. (28) 
A retrospective study on necropsy material, in Singapore, 
demonstrated HBV antigen in formalin fixed paraffin embedded 
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tissues. Orcein method was used. The results showed orcein positive 
liver cells in 22 out of 52(42.3%) and 37 out of 50(74%) of cirrhosis and 
HCC respectively, while only 5 out of 113(4.4%) cases of normal liver 
gave positive results. There is significant difference in frequency of 
orcein positive and orcein negative cirrhotic livers. These results 
suggest the etiological relationship between HBV s-Ag and HCC. (30) 
1.6.2.3. Treatment: 
Antiviral treatment is the only way to reduce morbidity and 
mortality from chronic HBV infection. Conventional interferon alpha 
and lamivudine have been the primary treatments to date. (31) 
1.6.3. Hepatitis C virus (HCV): 
HCV is a small enveloped RNA virus belonging to the family 
Flaviviradae and genus Hepacivirus. The HCV RNA genome is 9600 
nucleotides in length and encodes a single polyprotein that is 
posttranslationaly cleaved into 10 polypeptides including t3 structural 
protein and multiple non structural proteins (NS). The virus replicates 
at high rate in the liver and has marked sequence heterogeneity. There 
are 6 genotypes and more than 90 subtypes.(32) However, 55-85% of 
patients do not clear the virus but develop chronic hepatitis. Chronic 
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hepatitis C infection is often asymptomatic but it is usually associated 
with persistent or fluctuating elevations in ALT levels. (26)Cell culture 
systems for propagating HCV has yet to be established. A non 
primate animal model also does not exist. (26) 
Approximately 170million people worldwide are infected with 
HCV. The virus is transmitted primarily by blood and blood products. 
Sexual transmission between monogamous couples is rare, but HCV 
is more common in sexually promiscuous individuals. Perinatal 
transmission is also relatively low (<10%). Many individuals infected 
with HCV had no obvious risk factor. These persons probably have 
been inadverantly exposed to contaminated blood or blood 
products.(26) 
Epidemiologic studies detect 15-80% of patients with HCC 
harboring the virus depending on the area of study, being higher in 
Japan, Italy and Spain. PCR showed 62% of Spanish patients with 
HCC were positive for HCV RNA compared to 20% of southern 
African blacks. Like HBV infection, chronic liver injury leads to 
regeneration, cirrhosis and HCC. Chronic hepatitis occurs after 10-15 
years, cirrhosis after 20 years and HCC 30-40 years of chronic 
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infection. Thus far there is no evidence that HCV has a direct role in 
molecular pathogenesis of HCC, but is found to replicate in tumor 
tissue through insertional mutagensis.(8) HCV is also lymphotrophic 
leading to chronic lymphoprolifrative disorders. (33) 
In a cohort study of 455 HCV infected patients who were 
followed for a median of 7.4 years, multivariate analysis was 
performed. The conclusion was that only patients with advanced 
hepatic fibrosis or cirrhosis were at risk of developing HCC during 5 
year follow up. Among such patients, abnormalities of serum bilirubin, 
albumin, or prothrombin time indicate a high probability of 
complications. Patients without definite risk are at higher risk of 
complications possibly because of interaction between older age, 
duration of infection, country of birth and HCV genotypes 1b and 4.(34) 
In another study, 75 patients with HCV related HCC were 
retrospectively evaluated. Median age was 68 years and median 
duration of infection was 24 years. HCC was more frequently of 
diffuse type in patients less than 65. Diffuse type of HCC and tumor 
staging were the variables independently associated with worse 
survival in multivariate regression analysis.(35) 
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1.6.4. Viral Hepatitis in Sudan: 
Sudan is classified among the countries with HBVs-Ag 
endemicity of >8%.(1)  Several studies on viral hepatitis were carried in 
Sudan, mostly on HBV, showed exposure rate which varied from         
53-78%. HBs-Ag seroprevalence varied from 7-26% in the general 
population. It was highest in the south of Sudan.(Cited in 18)  
 Seroprevalence among asymptomatic blood donors was 12-
17%. Mother to child transmission was studied in Juba, south of 
Sudan; it was found that 55.5% of HBs-Ag positive mothers had 
children with positive serology whereas 11.4% of negative mothers 
had children positive for the virus.(18) 
A large study in Geziera region in the center of Sudan showed 
that 70% of HBs-Ag positive females of childbearing age were HBe-
Ag positive indicating that maternal infant transmission might be an 
important risk factor in that part of the country.(17, 18) 
In Khartoum state the seroprevalence of HBs-Ag in pregnant 
ladies was found to be 16.4% in a study carried at the antenatal clinic.  
Studies on children reported seroprevalence ranging from 7% 
among children presenting to the children's emergency hospital in 
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Khartoum to 24% among displaced children in a camp near 
Khartoum.(18)All these studies point to high prevalence among 
children and women of child bearing age. 
Unpublished data from the national health laboratory done 
among blood donors in Khartoum 1994-1996 where more than 65000 
blood donors were screened, 14% were found to be HBs-Ag positive. 
In Gaziera region, the prevalence was 17.5% (1992). In Juba, 
seroprevalence of 12.3 was estimated (1994). In patients with cirrhosis 
HBs-Ag was 31% (1989) in one study and 61% in another. (17, 18) 
Prevalence of HCV was about 2% in western Sudan and 3% in 
Juba (1994) as reported in two studies. In the Juba's study no 
association was found between blood transfusion and scarification 
unlike that with HBV. HCV antibodies were found to be as high as 
34% among haemodialysis patients in Khartoum (1995). (18) 
1.6.5. Alcohol and HCC: 
  Alcohol is not directly carcinogenic but can cause HCC 
through cirrhosis. About 55% of macronodular cirrhosis develops 
HCC.(8) Abstinence has shown higher frequency of macronodular 
cirrhosis leading to HCC. (8, 36) 
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    Chronic alcohol use of greater than 80 gm/day for more 
than 10 years increases the risk for HCC approximately 5 fold. Lesser 
amounts than 80 gm/day are associated with a non-significant risk for 
HCC.  Alcohol is the most common cause in the USA and Italy (32 
and 45% respectively). 
  The mechanism by which alcohol causes HCC are not 
completely understood but may include chromosomal loss, oxidative 
stress, a decreased retinoic acid level in the liver, altered DNA 
methylation, and genetic susceptibility. (36) 
Several epidemiologic studies suggest that chronic alcoholics 
are at risk of viral infections. Clinical and basic research has 
demonstrated that alcohol not only worsens the natural history of 
chronic viral hepatitis, but also seems to interact with viral replication 
cycle leading to an unusual viral serum profile and/or modification in 
the serum concentration of viral particles. Infection with HBV and 
HCV are a major risk for the development of hepatocellular carcinoma 
in excessive drinkers who should be protected against the viruses.(37) 
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1.6.6. Aflatoxins: 
1.6.6.1. Introduction: 
  Aflatoxin is a naturally occurring mycotoxin produced by 
two types of mold: Aspergillus flavus and Aspergillus parasiticus. 
Aspergillus flavus is common and widespread in nature and is most 
often found when certain grains are grown under stressful conditions 
such as drought. The mold occurs in soil, decaying vegetation, hay, 
and grains undergoing microbiological deterioration and invades all 
types of organic substrates whenever and wherever the conditions are 
favourable for its growth. Favourable conditions include high 
moisture content and high temperature. At least 18 different types of 
aflatoxin are produced in nature with aflatoxin B1 considered as the 
most toxic. While the presence of Aspergillus flavus does not always 
indicate harmful levels of aflatoxin, it does mean that the potential for 
aflatoxin production is present. 
Enzyme linked immunosorbent assay (ELISA) monoclonal 
antibody affinity chromatography, or fluorescence technology are 
used to detect aflatoxins in industry. High pressure liquid 
chromatography, (HPLC) is performed.(38) 
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Aflatoxins are potent toxic, carcinogenic, mutagenic, 
immunosuppressive agents produced as secondary metabolites. 
Aflatoxins normally refer to the group of difuranocoumarins. Among 
18 different types of aflatoxins identified major members are aflatoxin 
B1, B2, G1 andG2. Aflatoxin M1 and M2 are major metabolites of 
AFB1 and B2 respectively, found in milk of animals that have 
consumed contaminated feed. (39) 
Aflatoxins play an important part in modifying the risk of liver 
cancer associated with hepatitis B. After being metabolized in the liver 
the toxin can bind guanine in DNA, resulting in mutations. This 
mutation is common in primary cancers from areas of high exposure 
to aflatoxin, which provides evidence of a carcinogenic role for the 
toxin. It was reported that in hapatocellular carcinoma- cases exposed 
to aflatoxin B1, mutation of P53 gene is fixed at codon 249 third base 
and takes the form of G to T transversion. It appears that it is a 
definite marker of mutation, which is induced by aflatoxin B1mutagen 
and is applicable for molecular epidemiology survey of aflatoxin B1 
exposure among heptacellular carcinoma cases.(2, 40, 41)  
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  World wide epidemiological studies showed that the 
mutation in codon 249 was strictly specific to countries in which food 
is contaminated to aflatoxinB1. In Mozambique, for example more 
than 50% of the mutations were found in codon 249 and aflatoxinB1is 
a common contaminant. 
A similar situation has been observed in various parts of 
China, which differ in their levels of aflatoxin exposure. In countries 
which do not consume contaminated food, the rate of P53 mutation in 
HCC is low and the mutations are scattered in the central part of P53, 
as for the other types of cancer. It has been demonstrated both in vitro 
and in vivo that this is due to the very high sensitivity of the P53 
codon 249 to the action of aflatoxin B1. This observation along with 
the fact that this 249 mutation is deleterious for P53 function, explains 
this mutational hot spot.(41) 
1.6.6.2. Aflatoxins and cancer in humans: 
AflatoxinB1 is proved to be a liver carcinogen in a variety of 
experimental animals. Types of cancer described include HCC (rats), 
cholangiocarcinoma (hamsters), lung adenomas (mice), osteogenic 
sarcoma, adenocarcinoma of the gall bladder and carcinoma of the 
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pancreas (monkeys). An increased incidence of HCC was reported in 
south east of the USA, daily intake of AflatoxinB1 was 13-197 ug/kg 
body weigh compared to those in northern and western area with 
daily intakes of 0.2-0.3 ug/kg body weight. 
  In China, a strong correlation between the intake of peanut, 
peanut oil and corn had increased mortality rate for liver cancer in 
four villages were reported in five inhabitants groups. The median 
daily concentrations of M1 metabolite were (16.46, 8, 29, 4.78 and                         
1.21 ng/person). They suggested that further analysis of M1 in the 
urine can be used as an index for human exposure to AflatoxinB1 in 
epidemiological studies. 
Immune response in humans to aflatoxin: 
Antibodies to Aflatoxin B1 are considered indicative of 
exposure. Their presence may not be related to disease. Workers 
handling animal feed exposed to aflatoxins were examined for 
alteration of tumor necrosis factor in plasma. Air borne concentration 
of aflatoxin B1 was 0.99 ng /m3. Exposed workers had increased 
levels of TNF- alpha and concomitant changes in serum LDH 
isoenzyme activity.(Cited in 40) 
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1.6.7.  Non alcoholic fatty liver (NAFL): 
   Epidemiological studies have shown that obesity and 
diabetes mellitus are risk factors for HCC. Both are associated with 
NAFL disease, and case reports have shown progression of NAFL to 
cirrhosis and HCC. The mechanism involves replicative senescence of 
steatotic mature hepatocytes and compensatory hyperplasia of 
progenitor ovalocytes as a reaction to chronic injury due to ongoing 
steatohepatitis and resultant hepatic fibrosis. Growth factors 
associated with chronic inflammation, type- 2 Diabetes, and DNA 
mutations as a result of lipid peroxidation probably play a role in 
clonal expansion and HCC progression. Well documented case 
reports suggest that HCC can arise in the setting of non-alcoholic 
steatohepatitis with cirrhosis particularly in older male patient. (42) 
In a study performed in one hundred five patients with HCC 
in the USA, mean age was 59, 67% were men and 67% were non 
Hispanic white. The most common etiology of liver disease was 
hepatitis C 51% and cryptogenic cirrhosis 29%. Half of the patients 
with cryptogenic cirrhosis had histological or clinical features 
associated with nonalcoholic fatty liver disease. Nonalcoholic fatty 
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liver disease accounted for at least 13% of the cases. They concluded 
that NAFL might be a possible underlying cause for HCC. (43) 
1.6.8. Obesity: 
A study was done to determine whether obesity is an 
independent risk factor for HCC in patients with cirrhosis. Explanted 
liver specimens from a national database on patients undergoing liver 
transplantation were examined for HCC, and the incidence was 
compared among patients with varying body mass indices according 
to the etiology of cirrhosis. A multivariate analysis was used for 
controlling other potentially confounding variables such as age and 
sex. Among 19,271 evaluated patients, the overall incidence of HCC 
was 3.4% (n=659) with slightly higher prevalence among obese 
patients compared with lean patients. They concluded that obesity 
was an independent predictor for HCC in patients with alcoholic 
cirrhosis (odds ratio: 3. 2; 95% CI, 1.5-6.6; P=0.002) and cryptogenic 
cirrhosis. The higher risk of HCC in obese patients is confined to 
alcoholic liver disease and cryptogenic cirrhosis but not to HBV or 
HCV. However they recommended that the findings need to be 
confirmed in a broader population of individuals with cirrhosis.(44) 
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1.6.9. Diabetes Mellitus: 
Investigators in Texas conducted a hospital based case control 
study among 115 HCC cases and 230 non-liver cancer matched 
controls. Using conditional logistic regression, they concluded that 
chronic hepatitis C infection, chronic hepatitis B, heavy alcohol 
consumption, and diabetes mellitus were all associated with 
developing HCC.  
Independent of each other HBV, HCV, diabetes mellitus, and 
heavy alcohol consumption were found to contribute to 16, 22, 20, and 
32(%) of HCC patients. Some of these risk factors had synergistic 
interactions regarding HCC, i.e. between heavy alcohol consumption 
and chronic hepatitis virus infection (Odd Ratio 53.9:95%, CI 7-415.7) 
and diabetes mellitus (Odd Ratio 9.9:95%, CI.25-39.3). The authors 
concluded that the most important finding is the synergy between 
heavy alcohol consumption and chronic hepatitis virus infection as 
well as diabetes mellitus independent of each other, in the etiology of 
HCC. (45) 
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1.6.10. Hepatitis GV: 
The recently identified hepatitis G virus (HGV) is a 
hepatotropic RNA virus belonging to the Flaviviridae family. The 
virus causes chronic virema, and exposure to blood products is a 
recognized route of transmission in humans.  
A population-based, case-control study involving 144 non-
Asian patients with hepatocellular carcinoma and 252 community 
controls of similar age gender and race was conducted in Los Angeles, 
California. Study subjects were assessed for serologic markers of 
infections with the hepatitis B virus, hepatitis C virus (HCV) (anti-
HCV and HCV RNA), and HGV (HGV RNA). Twelve of the 144 
hepatocellular carcinoma patients (8.3%) and 5 of the 252 control 
subjects (2.0%) were positive for serum HGV RNA. The presence of 
HGV RNA in the serum was associated with a statistically significant 
54-fold risk of hepatocellular carcinoma (95% confidence limit, 1.8, 16, 
6) and the excess risk for hepatocellular carcinoma among HGV–
infected individuals was independent of the effects of hepatitis B and 
hepatitis C infection. The chronic infection with HGV may play a role 
in the development of hepatocellular carcinoma. (46) 
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Based on the data from China, Japan, Africa, United Kingdom 
and others, HGV might not play an important role in the development 
of HCC.(29) 
A retrospective study was performed to determine the 
prevalence of HBV, HCV and HGV genomes in formalin-fixed 
paraffin-embedded liver tissues from HCC patients in various 
geographic areas, the prevalence of each hepatitis virus in the liver 
tissues was different in the different countries. This study suggested 
that there was no evidence of any relation between HGV infection and 
development of HCC.(47) 
1.6.11. Cigarette Smoking: 
In Japan alcohol and cigarette smoking were observed as risk 
factors of HCC and synergism between them was observed. Ming-
Whei et al studied P53 genetic polymorphism as a modulator of HCC 
risk in relation to chronic liver disease, familial tendency and cigarette 
smoking in HBV carriers. Both cigarette smoking and glutathione           
s-transferase M1 genotype modified the risk of HCC associated with 
the P53 polymorhism. The risk increased significantly in the P53 
genotype among smokers (odds ratio =6.46; CI 95 %.). (48) 
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1.6.12. Drugs, Medications and Chemicals 
Female hormones and protein building steroids are associated 
with the development of hepatic adenomas.(21,24,25) Hepatic adenomas 
have the potential to become malignant.(21,25) 
Pesticides: 
Hexochlorobenzene is a pesticide which was used extensively 
in the past in Sudan. It is a chlorinated hydrocarbon which is 
hepatotoxic and neurotoxic. Lidane (a gamma hydrocarbon) is 
another pesticide which can cause hyperplastic nodules and HCC in 
mice at doses of 160 mg/kg.(49)  
1.6.13. Heamochromatosis: 
HCC will develop in up to 30 % of patients with hereditary 
haemohromatosis. Unfortunately, once cirrhoisis is established, 
effective removal of excess iron will not reduce the risk of developing 
HCC. The risk of iron overload for the development of HCC was 4.1 
in black Africans, which is similar to that of haemochromatosis in 
Caucasians. A role of family history independent from and interacting 
with known risk factors for HCC was also reported, the odds ratio 
was 2.4.(50) Other illnesses associated with HCC development on top 
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of cirrhosis are ataxia telengectasia, tyrosinemia, porhyrias, 
hypercitrulinemia, membraneous obstruction of the inferior vena 
cava, and glycogen storage diseases (type 1 and 3). (21, 51) 
1.6.14. Synergism between different risk factors: 
1.6.14.1. HBV and HCV: 
In a study in Naples (Italy) a group of 205 patients who were 
HCV RNA positive, HBs-Ag/anti-HBs negative were followed over 
four years. Presence of anti-HC is considered a marker of silent 
infection. The findings suggest that silent HBV infection in anti HCV 
positive chronic hepatitis enhances the severity of liver disease. 
Evidence was also found that in patients without silent HBV infection 
there is a correlation between the presence of HCV genotype 1 and the 
severity of the disease.(52) 
1.6.14.2. HBV and Aflatoxin: 
The highest incidences of HCC and the youngest patients 
affected is found in china, sub-Saharan Africa, Taiwan, each of which 
is hyperendemic for HBV and  has a high rate of dietary exposure to 
aflatoxin B1. The latter two are well known in the multifactorial 
aetiology of human HCC.(53) 
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A number of possible mechanisms have been suggested. 
Chronic HBV infection may induce the cytochrome P450s that 
metabolizes inactive aflatoxin B1 to the mutagenic AF-B18,                     
9-epoxide.(8,53) Necrosis and regeneration of hepatocytes together with 
the generation of oxygen and nitrogen reactive species resulting from 
chronic HBV infection increase the likelihood of AFB1-induced P53-
249 and other mutations. Nuclear excision repair which is normally 
responsible for removing AFB-1 DNA adducts is inhibited by HBVx 
protein favouring the persistence of existing mutation. This protein 
increases DNA mutations including P53- 249 mutation leading to 
uncontrolled cell cycling. (53) 
1.6.14.3. Alcohol and HCV: 
Excess alcohol consumption can worsen the outcome of 
chronic HCV infection.(31) Alcohol use is associated with lower 
responses to therapy and higher HCV RNA levels. Current evidence 
showed that heavy alcohol drinking is associated with worse outcome 
of HCV infection. (54) 
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1.7. Clinical presentation  
Most HCC patients have a past history of chronic liver disease 
from different causes the major clinical risk factor is liver cirrhosis. 
HCC should be considered in any patient with chronic liver disease 
whose clinical status indicates sudden decompensation. 
Unfortunately the disease is clinically silent until it is well advanced 
or tumor diameter has exceeded 10cm. 
 The presenting symptoms in patients with HCC include 
abdominal pain, malaise, anorexia, weight loss and vomiting. The 
most common clinical signs are hepatomegaly, ascites, fever, jaundice, 
and spleenomegaly. 
  Few patients present with paraneoplastic syndrome, 
manifested by erythrocytosis, hypercalcaemia, hypoglycemia, and 
carcinoid syndrome, dysfibrinogenemia, cryoglobulinemia and 
hypercholesterolemia. (51,55) 
  There may be serum elevation of proline hydroxylase, ectopic 
production of human chorionic gonadotrophins and progesterone. (51) 
    Data from Flienker et al stated that 91% present with 
abdominal pain, 43% abdominal swelling and 35% with weight loss. 
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Other symptoms include weakness (31), anorexia (27), jaundice (7), 
and vomiting (8%).( 55) 
The most common physical signs were hepatomegaly in 90%, 
followed by spleenomegaly in 65%, ascites52%, jaundice 41%, and 
fever 38%.(55) 
  In Sudan, 67% of HCC patients presented with abdominal 
swelling, hypochondrial pain 42%, weight loss 21%, epigastric pain 
6%, anorexia16%, jaundice30%, and fever in 13% of cases. 
Signs: hepatomegaly 96%, spleenomegaly 33%, ascites 32%, 
and hepatic encephalopathy complicated 4% of patients. (17) 
1.8. Diagnosis: 
  Anyone with chronic liver disease whose status is declining 
should be assessed thoroughly. Basic laboratory evaluation should 
include a complete blood count, LFT to help detect HCC, AFP should 
be measured; a level exceeding 500 ng/dl is considered a positive 
finding. More sensitive tests such as I L-2 receptor levels are currently 
being developed and results are encouraging. (55) 
  Paracentesis should be performed if imaging studies or 
physical examination revealed ascites. Bloody ascites is found in 20% 
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of patients. Fluid can be obtained for cytological evaluation.(55) The 
primary method of diagnosis is ultrasonography (US). Other imaging 
techniques used include computed axial tomography (CT scan) or 
magnetic resonance imaging (MRI). Once imaged, diagnosis is 
confirmed by percutaneous biopsy. 
1.8.1. Imaging Techniques: 
1.8.1.1. Ultrasound (US): 
  US appearance of HCC is variable. The quality of US is user 
dependent. The entire liver should be evaluated carefully. Small 
HCCs can be homogenously hyperechoic and can mimic 
haemangioma.  
 Good quality US with careful evaluation of the liver can be a 
screening examination for patients at risk in combination with serum 
AFP evaluation. However sensitivity of US for these lesions in a 
cirrhotic liver is limited. Vascular invasion can be evaluated 
adequately using Doppler color imaging with convenient ultrasound. 
Thrombus in hepatic and portal veins as well as inferior vena cava can 
be imaged. Portal venous invasion is more common in HCC but 
hepatic vein invasion is more specific. 
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Degree of confidence: Small masses require further evaluation 
since they mimic haemangioma, and metastatic disease. Imaging with 
CT or MRI during dynamic contrast enhancement shows the typical 
peripheral contrast enhancement pattern of haemangioma. 
MRI or CT can further characterize many non specific hepatic 
masses seen on US. (50) 
1.8.1.2. Computed tomography (CT) scan: 
CT appearance of HCC varies depending on tumor size and 
the imaging phase. The most common attenuation pattern is iso and 
hyperattenuation on pre-arterial and venous phases respectively.  
Unenhanced CT typically reveals an iso-hypodense mass. CT scan 
also evaluates complication of HCC such as portal-venous or hepatic-
venous invasion.  Underlying disease can be evaluated which can 
indicate the aetiology, e.g. cirrhosis and haemochromatosis. 
Degree of confidence: in the setting of an abnormal liver with 
elevated AFP, a vascular mass, and a necrotic mass in the liver 
strongly suggests HCC.  False negative CT imaging can occur. Even 
the best scan can face difficulty detecting small lesions. Good quality 
scans as triphasic scanning is the best. 
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1.8.1.3. Magnetic resonance imaging (MRI): 
HCC appearance varies on MRI depending on multiple factors 
such as hemorrhage, presence of fibrosis, histological pattern, degree 
of necrosis, and the amount of fatty change.  MRI is the best imaging 
method to detect the presence of a tumour capsule. MRI can help 
differentiate cirrhotic nodules from HCC. If the mass is bright on           
t2-weighed images, it is HCC until proven otherwise. 
   Complication is evaluated well by MRI, e.g. vascular 
invasion. Degree of confidence: some well differentiated HCCs can 
mimic cirrhotic nodules on MRI. Some HCCs can contain Küpffer 
cells thus having signal characteristics similar to normal liver when 
contrasted with iron oxide. 
1.8.1.4. Nuclear medicine: 
On gallium scan, up to 90% of HCCs demonstrate uptake of 
radiopharmaceutical gallium. This may help distinguish regenerating 
nodules of cirrhosis which do not label with gallium. On liver spleen 
scan, a sulphur colloid label demonstrates an area of decreased label. 
Signs of cirrhosis should be looked for. 
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1.8.1.5. Positron emission tomography (PET): 
PET with flurodeoxyglucose (FDG PET) is useful in assessing 
the differentiation and staging of moderately and poorly 
differentiated tumors. Sensitivity for detection ranges from 50%-70%. 
This limit is due to low level of uptake of FDG in well differentiated 
tumors. It can be used with CT scan to assess for extra hepatic 
spread.(50)  
1.8.2. Liver biopsy: 
The definitive diagnosis of HCC depends on the histological 
examination of the lesion, especially in AFP negative patients. 
Ultrasound or CT guided percautenous biopsy with 22 gauge needle 
usually provides sufficient tissue for diagnosis. There is minimal risk 
of bleeding or seeding of tumor along the needle. However in patients 
with significant high AFP levels who are eligible for HCC resection or 
transplantation, liver biopsy is not recommended so as to avoid risk of 
tumor spreading before surgery.(1) 
Complications: 
• Implantation along the tract, so biopsy is avoided if the diagnosis 
is highly suggested. 
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•  Intrabdominal haemorrhage.(51) 
1.8.3. Alfa feto protein (AFP): 
AFP is an alpha glycoprotein with homology to albumin. It 
maintains osmotic pressure during fetal life and is produced by the 
yolk sac, gastrointestinal tract and the liver. AFP can be found in high 
concentration during fetal life reaching a peak of 3 mg/ml at 12 weeks 
during human fetal life development. The serum AFP falls with 
increasing gestational age. At 4-5 weeks after birth, it can be detected 
usually in low concentration. In healthy adults, 10-20 ng/ml can be 
found in the circulation. It rises normally in pregnancy reaching 500-
550 ng/ml.(56) It is also elevated in benign liver disease as well as 
cancer. It is elevated in testicular tumors containing embryonic or 
endodermal sinus elements. A definitive positive marker value is 
highly sensitive indicating relapse or response to treatment.(56,57)AFP 
is rarely elevated in healthy persons. Elevation occurs in certain 
hepatic disease especially acute viral or drug induced hepatitis and 
conditions associated with hepatic regeneration. Moreover increased 
levels of AFP were found in hereditary diseases e.g. congenital 
tyrosinemia, ataxia telengectasia and in the amniotic fluid in 
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congenital nephrosis of Finnish type. It is used in screening of neural 
tube defects.(57) 
 Serum AFP is a useful marker in HCC and germ cell tumors 
the only conditions associated with elevations greater than 500ng/ml. 
In HCC, which is one of the common tumours worldwide AFP may 
be of use in screening.(56) 
Sell termed AFP as the single most discriminating laboratory 
test indicative of malignant disease. As such it could be valuable in 
screening for HCC in high-risk populations.(56) 
A multicentric retrospective case control study conducted in 
HCV patients comparing the AFP values in HCC patients (n=163) and 
cirrhotic (n=149) in African Americans and other ethnic groups 
concluded that AFP greater than 200 ng/ml can be used to confirm 
HCC in patients with HCV related cirrhosis and a hepatic mass.(58) 
 Mohammedian found 74% of the HCC patients (n=100) had 
elevated serum AFP level. Another 51% had values above 400 ng/ml; 
all except three of all the patients screened (study on liver diseases) 
were HCC patients. These three patients had liver cirrhosis and were 
all positive for HBV and have high PIVKA-II values. He suggested 
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that levels of 400 ng/ml represent a good cut off point to differentiate 
HCC from other liver diseases.(17) 
1.9. Treatment and Prognosis: 
1.9.1. Treatment:  
Important features that guide treatment include:- 
1. Size. 
2. Stage. 
3. Spread.  
4. Involvement of liver vessels.  
5. Presence of a tumour capsule. 
6. Presence of extrahepatic metastases.  
7. Presence of daughter nodules. 
8. Vascularity of the tumor. 
1.9.1.2. Surgery: 
Surgery to remove the tumour or liver transplantation can be 
used to treat small or slow-growing tumours if they are diagnosed 
early. Indications for surgery include: Small tumors <2 cm, limited 
stage 1, 2 and good hepatic function. It can achieve 5-year survival as 
60% to 70% and rarely cure the disease. For treatment with curative 
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intent the gold standard is surgical resection with either partial or 
total resection, followed by liver transplantation.  
1.9.1.3. Percutaneous Ethanol injection (PEI): 
Among non-surgical options this is usually the treatment of 
choice for patients with small (3cm or less in diameter) tumors. In 
Asia it is used as adjuvant to resection for patients who are poor 
surgical candidates but have small tumors all <3 cm, PEI achieves a 
survival rate similar to that of resection. It is inexpensive and widely 
available.  
1.9.1.4. Transcatheter Arterial Chemoembolization (TACE):  
It is usually performed in the treatment of large tumors (large 
than 3cm and less than 4 cm in diameter) most frequently performed 
by intra-arterial injecting an infusion of antineoplastic agents mixed 
with iodized oil (such as lipiodol). 
1.9.1.5. Radio frequency ablation:  
Here high frequency radio-waves are used to ablate the 
tumors. Combined PEI and TACE can be used for tumors larger than 
4cm in diameter although some Italian groups have had success with 
larger tumors using TACE alone.(59) 
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1.9.2. Prognosis: 
Although HCC is a slow growing tumor, it is often fatal 
because it is usually not discovered until the disease is advanced. It 
takes 20-30 years to be clinically evident. Most studies show survival 
less than one year after discovery of the tumor (5-10 month). 
 Features associated with poor prognosis include more than 
three nodules, absence of capsule, presence of capsular invasion, 
tumor size over 5cm; tumor portal or hepatic thrombosis and spindle 
and giant histological types.  
 Minute small (2-5 cm) encapsulated well differentiated liver 
cell carcinomas are usually associated with good prognosis (overall 
survival rates of 63%) especially if encapsulated.(59) 
The correlation between TNM classification of HCC and local 
cancer-free survival time after hepatectomy in 1725 cases in China 
showed that TNM stage in one of the most significant prognostic 
factors determining tumors free survival after HCC resection. There is 
no prognostic significance difference between stages II and I.(60) 
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1.10. Prevention:  
Preventing viral hepatitis infections is one key strategy to 
reduce the burden of liver disease. Hepatitis B vaccination in infancy 
has been shown dramatically to reduce persistent infection with 
vaccine efficacy of 94% at 9 years of age.(61,27) The key strategy for 
preventing HCV infection is through public heath programmes for 
safe injection. About 350 million carriers of HBV in the world continue 
at high risk of cancer.  
This is where aflatoxin is important. At individual level, diet 
can be modified but this is not an option for the poor rural areas. 
Chemopreventive agents (oltipraz and chlorophyllin) reduce the 
burden of harmful metabolites have been studied. Agricultural 
strategies may be more effective in China and Africa. Genetic 
modification of crops to enhance fungal resistance, and bio- control by 
flooding field with non toxigenic fungi is promising. Much of 
contamination of food occurs after storage. Methods to reduce 
humidity by drying in sun, on mat, discarding visible moulds kernels 
or nuts before storage can be very effective.(2) 
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Coffee appears to have a real but moderate effect in reducing 
the risk of HCC. Various components of coffee have such favorable 
effects but none has proved. HCC should be added to other digestive 
tract cancers on which a favouring role of coffee drinking is suggested 
including oral, pharyngeal, oesophageal and colorectal cancers. (62) 
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JUSTIFICATION 
 
   Hepatocellular carcinoma is a frequently encountered tumor 
in Sudan and it shows some predilection to special areas in the 
country. Unlike other tumors its causal factors are well identified both 
epidemiologically and experimentally and most if not all are 
preventable. A through study of these factors and their epidemiologic 
distribution will help directing prevention. A basic knowledge of the 
histology of the tumor will provide information about its growth 
characteristics and may give hints about outcome.  
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OBJECTIVES 
 
General objectives: 
The study aims to shed some light on the clinical and 
pathologic aspects of hepatocellular carcinoma in patients at Ibn Sina 
Specialized Hospital. 
 
Specific objectives: 
1. To study the morphological subtypes of HCC.  
2. To study the relative frequency of risk factors predisposing to 
HCC. 
3. To determine the age and sex distribution. 
4. To determine the presence of occupational hazard.- 
5. To determine the size of the tumor at diagnosis.  
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MATERIALS AND METHODS 
2.1. Study Design: 
This is mainly a retrospective descriptive study.  
2.2: Study area and duration: 
The study was carried out at Ibn Sina Specialized Hospital 
(ISH)- Khartoum. The study covered the hepatocellular cases from 
January 2003 to December 2004.  
ISH is a referral specialized hospital. There is a well 
established gastroenterology unit. Cases with liver diseases and other 
gastrointestinal diseases are referred from all regions of Sudan and 
other hospitals in Khartoum state. Trained staff performs liver 
biopsies.  
The majority of liver biopsy specimens are send to ISH 
laboratory for histological diagnosis.  HCC patients are followed 
every Wednesday in the liver clinic. 
2.3. Samples: 
  Archived slides of adult HCC cases, diagnosed in the 
histopathology, Laboratory(ISH) from 2003-Dec.2004 inclusive were 
reviewed. A total of 69 slides were found and 57 cases were of good 
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enough quality and had an adequate amount of tissue and consistent 
diagnosis to be reevaluated. 
All the slides were reviewed by experienced pathologists and 
the tumors were classified according to the WHO classification of 
histological types (Hirohashi et al, 2000). The tumors were graded 
according to the WHO grading conviction. Special features, such as 
the predominant cellular variant, presence or absence of Mallory 
bodies, pale bodies and bile are noted.  
When a tumor could not been classified for any reason, i.e. too 
few tumor cells in the slides, other or undetermined was given as 
subtype. 
Demographic data were based on data obtained from the 
archived histopathology request forms kept in the laboratory 
supplemented by data obtained from the medical record section of the 
HCC referred clinic for the same patients. 
About six patients had been directly interviewed during data 
collection in the referred clinic and ward.  
Clinical and other laboratory data included the level of AFP, 
HBs-Ag, anti HCV antibody, alcohol consumption and clinical 
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presentation. Imaging techniques used were recorded together with 
the gross appearance of the tumor (solitary, nodular, or diffuse) 
WHO. Tumor size was also analyzed. 
Six patients were diagnosed outside ISH by eminent 
histopathologists. They were included in the analysis of the 
demographic and clinical data. 
Therefore, a total of 63 HCC cases were included in the study. 
Only 57 patients had reviewed slides. 
2.3.1. Inclusion criteria: 
1. HCC patients whose diagnosis is histologically confirmed during 
the study period.  
2. HCC patients whose liver biopsies were diagnosed outside the 
hospital by expert histopathologists. 
2.3.2. Exclusion criteria: 
1. HCC patients who were diagnosed based on the presence of 
liver mass by imaging techniques and high AFP level 
(>400ng/dl) only. However they were included only for 
comparisons at the end of discussion. 
2. Patients whose histological material was missed. 
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2.4. Tools and methods: 
The histological specimens obtained after liver biopsy are fixed 
and embedded in paraffin. Sections are stained using heamatoxylin 
and eosin stain. Experienced histopathologists reviewed the slides. 
The pattern, differentiation and histological variants were identified 
according to the WHO criteria (refer to literature review). 
A questionnaire was used to collect the demographic data and 
clinical data. The data was distributed into a master sheet and 
analyzed using Stata computer program. 
  Not all the records are complete for every variable and some 
were referral cases from other hospitals, so some data will be missing. 
The data obtained was analyzed as a factor of the sum of each 
variable. 
2.5. Data analysis: 
 Data was obtained using Stata computer system version 6. 
Fisher's exact p-values were used to test the significance of some 
correlations.  
 
 
 71 
RESULTS 
3.1. General consideration: 
Sixty three cases were included in our study, which were 
previously diagnosed as hepatocellular carcinoma in Ibn Sina 
Specialized Hospital in the study period. The information about the 
whole sample was used only in estimating the sex distribution. 
However information about other variables is not complete for all the 
cases included in our study, so the distribution of any parameter will 
be a factor of the sum of that parameter. Pictures of some slides were 
selected to demonstrate various histological features.  
Figure 3.1 estimates the mean age of the studied population to be 
58.13 years. Males dominated females in the ratio of 3.8:1 as shown in 
(Fig.3.2). 
Figure 3.3 shows that 50% of the patients originated from the 
western regions. 
Farmers represented the majority of the patients (52%) as 
shown in (Fig. 3.4) 
Figure 3.5 shows that most of the masses were solitary (56.7%). 
Tumour size larger than 10 cm comprised 80% of the ultrasound 
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readings studied among the HCC patients as shown in (Fig. 3.6) 
The compact subtype represented 42 % among other subtypes 
as drawn in (Fig. 3.7). 
Figure 3.8 shows that the clear cell variant represented 21%, 
while no section showed giant cells.  
Figure 3.9 shows that half of the specimens were poorly 
differentiated, while only 17% were of good differentiation. 
Figure 3.10 shows that 40% of the trabecular variant were of  
good differentiation, while 80% of the compact subtype were poorly 
differentiated.  
Figure 3.11 demonstrates that 71% of the studied population 
had alpha-fetoprotein >400 ng/dl.  
Figure 3.12 shows that 41% of the studied cases were positive 
for hepatitis B. 
Figure 3.13 estimates that 19% of the studied cases were 
positive for hepatitis C.  
Figure 3.14 shows that 47% the studied cases were positive for 
alcohol consumption.  
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Figure 3.15 demonstrated that 87% of the HCC cases were 
cirrhotic.  
Figure 3.16 shows the distribution of each risk factors in the 
studied population excluding the unknown cases.  
Figure 3.17 compares the frequencies of each risk factor with 
the total number of patients including the unknown cases. 
Table 3.1 shows that 25% of the studied cases from the 
Northern region were positive for hepatitis C, while 33% from central 
Sudan were positive to hepatitis C. 
Table 3.2 shows that 50% of cases from the West were positive 
for hepatitis B, followed by the central region (25%), while non from 
the North.  
Table 3.3 demonstrates that all patients consuming alcohol had 
cirrhosis.  
Plates 18 -26 describe the different histological subtypes and 
cellular variants of hepatocellular carcinoma specimens.  
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Figure 3.1: Distribution of the studied population (54 HCC patients) 
by age, ISH, 2003 -2004. 
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Figure 3. 2: Distribution of the studied population by sex, 
 ISH, 2003 – 2004 (n= 63) 
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Figure 3.3: Distribution of the studied population by origin, 
 ISH, 2003 – 2004 (n= 63) 
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Figure 3.4: Distribution of the studied population by occupation, 
 ISH, 2003 – 2004 (n= 23) 
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Figure 3.5: Distribution of hepatocellular carcinoma by gross 
morphological appearance as seen ultrasonography, ISH, 2003 – 2004  
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Figure 3.6: Distribution of hepatocellular carcinoma by size as 
measured by U/S (n = 24), ISH, 2003 – 2004 
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Figure 3.7: Distribution of hepatocellular carcinoma by histological 
subtypes, ISH, 2003 – 2004 (n = 57) 
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Figure 3.8: Distribution of hepatocellular carcinoma tumor by 
cellular variants in the studied population, ISH, 2003 – 2004 
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Figure 3.9: Distribution of hepatocellular carcinoma tumor by WHO 
histological grade, ISH, 2003 – 2004 
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Figure 3.10: Distribution of hepatocellular carcinoma tumor by WHO 
grade among different histological patterns (n =53), ISH, 2003 – 2004 
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Figure 3.11: Distribution of the studied population by high alpha-
fetoprotein level (>400 ng/dl), ISH, 2003 – 2004 (n = 21) 
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Figure 3.12: Distribution of the studied population by HBs-Ag, ISH, 
2003 – 2004 (n = 34) 
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Figure 3.13: Distribution of the studied population by anti-HCV ab, 
ISH, 2003 – 2004 (n = 32) 
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Figure 3.14: Distribution of the studied population by history of 
alcohol consumption, ISH, 2003 – 2004 (n= 36) 
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Figure 3.15: History of liver cirrhosis in HCC patients, ISH, 2003-2004  
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Figure 3.16:  Distribution of the studied population by identified 
risk factors, ISH, 2003 – 2004 
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Figure 3.17: Distribution of the study population by risk factors, 
ISH, 2003 – 2004 
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Table 3.1: Regional distribution of hepatitis C virus among HCC 
patients, ISH, 2003-2004 
Region HCV positive (%) HCV negative Total 
West 2 (11) 16 18 
North 1 (25) 3 4 
Central 2 (33.3) 4 6 
East 1 (50) 1 2 
south 0 (0) 0 0 
Khartoum 0 (0) 1 1 
Total 6 (19.3) 25 31 
 
P= 0.394 
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Table 3.2: Regional distribution of hepatitis B virus among HCC 
patients, ISH, 2003-2004 
Region HBV positive (%) HBV negative Total 
West 9 (50) 9 18 
North 0 (0) 4 4 
Central 2 (25) 6 6 
East 1 (100) 0 2 
south 1(100) 0 1 
Khartoum 0(100) 1 1 
Total 13 (39.4) 20 33 
P =0.106 
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Table 3.3: Correlation of Cirrhotic state with alcohol consumption 
among HCC patients, ISH, 2003-2004 
Cirrhosis Alcohol (yes) Alcohol (no) Total 
Present 11 7 18 
Absent 0 4 4 
Total 11 11 22 
 
P =0.090    
1-sided P value = 0.045 
 
 
 
 
 
 
 
 94 
 
 
 
Plate I:  Clear cell variant in HCC specimen (ISH) 
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Plate II: Pseudoacinar pattern(ISH) 
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Plate III: Trabecular pattern with fatty change (thin trabeculae) (ISH) 
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Plate IV: Thick trabeculae merging into compact subtype 
(centre)(ISH) 
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Plate V:  Compact pattern with trabecular pattern at the periphery 
(mixed differentiation) (ISH) 
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Plate VI: Compact (sinusoidal) pattern showing clear cells (ISH) 
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Plate VII: Scirrhous subtype (ISH) 
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Plate VIII: Spindle cell variant (poorly differentiated tumor) (ISH) 
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 Plate IX:  Poorly differentiated tumor with hyperchromatic nuclei 
and fibrosis(ISH) 
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DISCUSSION 
Hepatocellular carcinoma is a common malignancy in Sudan and is 
frequently encountered in Ibn Sina Specialized hospital. This study was 
designed to review the clinicopathologic features of HCC. 
A total of 63 cases were included, all being diagnosed by 
demonstrating malignant hepatocytes in liver biopsy specimens. Fifty- seven 
archived slides were retrieved and the tumor was analyzed into subtypes, 
histological grade and cellular variants. Clinical data was obtained from the 
request forms and medical records. However some data were missing.  
Age: 
The commonest age group at presentation was the seventh decade   
(60-69) accounting for 27%, with a mean age of 58.13 years (SD= 15.14). 
The youngest age was 30 years and 97 was the eldest.  Similarly two 
previous studies on HCC in Sudan found the common age at diagnosis was at 
51 and 55.3 years. (17) 
In Saudi Arabia most patients present in the sixth decade.(10) 
However, in Mozambique, being a high incident area the mean age was 33.4 
(n=328).(13) 
On the other hand in USA, where HCC is not a common malignancy, 
the mean age at presentation tends to be higher, at the seventh and eight 
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decades. Most of HCC patients in USA had a history of preceding 
cirrhosis.(15) 
Sex: 
Males dominated females in the ratio of 3.8: 1, this is in agreement 
with Mohammedien's (1993) and Zakie's studies (1991), with ratios of 4:1 
and 3:1 respectively. Fedail S S group (1978) reported a ratio of 6:1.(17,18) 
WHO claims that in high prevalence areas the ratio is more than 3.(1) 
In Saudi Arabia, it is 4:1.(10) 
This may be explained by the fact that male gender is more exposed 
to risk factors as alcohol and hepatitis BV infection. Also it is postulated that 
the male hormonal milieu affords more vulnerability to HCC development. 
Area: 
Almost 50% of the patients came from the west (Darfur and 
Kordofan), followed by the central (White Nile & Gaziera) region accounting 
for 22.2%. South and eastern Sudan were the least (3.7%) affected.  
All studies done in Sudan agreed that the west represents the highest 
incidence region. It represented 31% in one study, followed by the central 
region (26%), the south was only 2 %.( 17) 
The incidence of   liver cancer differs significantly among different 
ethnic groups living in the same geographical area. Also it differs among 
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migrants of the same ethnic groups living in different areas.(15) This 
epidemiologic observation may explain the less vulnerability of the southern 
to develop HCC inspite of high prevalence of HBV in the south.(18) 
In the same view, black Americans are twice more vulnerable to 
develop HCC as a white Americans.(15) 
Among African countries, West African countries like Nigeria and 
Senegal reports high prevalence rate of HCC mostly due to HBV. (11,12) 
Similarly in Sudan, the western region which could be estimated as 
extension of Sudan to the west both geographically and ethnically was the 
region with highest prevalence. Nine out of 18 western patients (50%) were 
positive for HBV. 
The south showed marked resistance to develop HCC in spite of the 
high prevalence of HBV there. (18) 
Explanation is not evident but may be related to some genetic factors 
or an environmental factor which protects against carcinogenesis. This needs 
to be clarified by further studies. 
Occupation: 
All females were housewives. More than half (52%) of the known 
occupations were farmers. The majority (74%) were either a farmer or a 
labour. No civil servants were included in the study. 
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This is in agreement with Mohammedien's study; the vast majority 
was farmers and labours. Civil servants were the least (6.8%). From the 
previous result it is evident that being a farmer induces more risk for 
developing HCC.(17) 
This can partly be explained by the fact that farmers are exposed 
more to aflatoxin which can be inhaled directly or in animal feed, drank with 
milk especially aflatoxin M2 or consumed in cereals.(40) 
This is supported in one study where workers handling animal feed 
and being exposed to mycotoxins including aflatoxin were examined for 
serum alterations in TNF alpha. Airborne concentrations of aflatoxin were 
0.99 ng\m3.exposed workers had been found to have increased levels of 
TNF-alpha and concomitant increase in LDH isoenzyme activity. (Cited in 40) 
Use of pesticides in agriculture as hexochlorobenzene (used in 1970) 
and lidane (gamma hydrocarbon) can lead to the development of hyperplastic 
nodules and HCC as shown in mice.(49) 
Aflatoxin also can cause pulmonary fibrosis through inhalation as 
reported in 2 farmers and one textile worker. (40) 
The above may indirectly suggests why farmers are at increased risk 
to develop HCC, either by consumption in cereals, drinking contaminated 
milk, exposure to animal feed products and inhalation. This is besides the fact 
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that they are not immune against other risk factors as in the general 
population. 
Relation of HBV and HCV to region of origin: 
Half (n=9) of those from the west examined for HBV were positive 
(n=18). However the correlation is not significant (P=0.106). Small sample 
size may have affected the result. 
Aflatoxin B1 and HBV act synergistically to increase HCC risk.(8,53)  
The effect of combined exposure to persistent HBV infection and dietary 
aflatoxin can be considered as the main etiology of liver cancer in the west, 
although the effect of aflatoxin is not evaluated scientifically in our study. 
This has been shown best in a cohort study in china. In it, the risk of 
liver cancer associated with HBV alone was a sevenfold increase over 
background, but the combination of HBV and aflatoxin increased this to a        
60 –fold risk. They have provided compelling evidence for a multiplicative or 
sub-multiplicative interaction between HBV and AFB1 in the genesis of 
human HCC.(2, 53) 
It seems that HCV is acquired sporadically, almost all regions show 
similar exposure risks, however the number of variables is comparatively 
small (fisher's exact test = 0.394). 
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Histological subtypes of HCC tumor: 
Compact subtype was the most common (42%) subtype. Trabecular 
subtype accounted for 26.3%. Mixed trabecular and pseudoglandular patterns 
has been present in 5 sections. Fibrolammelar variant was not detected.  
The problem of misclassification might have occurred in this study. 
The amount of tissue in needle biopsy may not represent the whole tumor and 
tissue distortion can lead to overestimation of compact subtype. The focal 
aggregation of collagenous stroma present in needle biopsy specimens may 
lead to overestimation of schirrhous subtype.  
A study in Saudi Arabia has shown similar pattern distribution. 
Compact was seen in the majority of specimens (n=60), followed by 
trabecular and pseudoglandular.(10) However, several studies in East Asia 
(Thailand) concluded that trabecular pattern was dominant, ranging from 43-
71%, followed by the sinusoidal and compact 9.0- 24%, scirrhous accounted 
for 8-1%. Fibrolammelar was the least, mostly arising in non cirrhotic 
livers.(23) The high prevalence of compact subtype in this study can be 
explained by the late presentation of patients at diagnosis (all tumor sizes 
were more than >5 cm).  
WHO claims that tumors of size less than 3 cm have well 
trabeculated histology.(1) In areas such as Thailand, where HCC is prevalent, 
 109 
tumors are expected to be discovered early. 
The prevalence of scirrhous and fibrolammelar are similar to that in 
other studies.(1,23) The predominant cellular variant if present has been taken 
as the main variant. Clear cellular variant was observed in 24% but is 
predominant in 21% only. Giant cell variant was not found. 
Mixtures of variants existed between clear and spindle cells in 2 
sections. Occasionally tumor giant cells and multinucleated cells are 
observed. 
In literature, clear cells were observed as the dominant variant in        
5-16% of cases, however 20-40% of HCCs contain few clear cells.(21) The 
fatty pattern is observed in one section since it is usually found in early well 
differentiated tumors. (1) 
Tumor grading: 
Undetermined subtypes were excluded in the tumor grading due to 
their unclassifiable nature or the presence of excessive fibrosis. 
Mixed differentiation also existed in 5 cases, with the more 
differentiated tumor at the periphery. 
It is not surprising to grade 50% of the specimens as poorly 
differentiated tumors. This is explained by patients presenting late with tumor 
sizes more than 5 cm in diameter. WHO Classification describes well 
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differentiated tumors as having a size of <3 cm in diameter. Mixed 
differentiation is an expected finding in HCC tumors because as the tumor 
expands, it tends to leave the poor differentiated tissue at the centre as it 
expands to involve the more differentiated recently turning malignant cells at 
the periphery. (1)  
Risk factors: 
Hepatitis B Virus: 
HBs-Ag was found to be positive in 41.2% of those examined for it 
(n=34). Previous results in Sudan showed high prevalence of HBV markers. 
All HBV markers were studied in 1993 in 100 patients. The majority (90%) 
at least have one marker, 60% were positive for HBs-Ag, 63 for anti-core 
antibody  and 10 were positive for anti- e. Carrier rate in controls was 7.4% 
for HBs-Ag.(17) 
In the four studies done on the relationship between HBV markers 
and HCC had all established a very strong association with HBV ranging 
from 38.5% to 67% in HCC cases. HCV was implicated in 11-17.3% of 
cases.(18) 
HBs-Ag seroprevalence in Sudan varied from 7-26% among the 
general population. It was highest in the south. (18)   However, the exposure 
rate varied from 53-78%.(18) 
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WHO classify Sudan among the countries with HBV endemicity of 
>8%. HBV associated risk for the development of HCC is obvious compared 
to the general population.(1) 
Although 59% were negative for HBs-Ag, this does not rule out 
infection, as other markers may be there as evidenced in Mohammedien's 
study, where the exposure to the virus was seen in 90% of the patients.(17) 
In one study, HBs-Ag negative and PCR positive patients, the 
positive rates of expression of HBx and P53 were 62% and54% being 
comparable to those in HBs-Ag–positive patients. The results of the study 
suggest that high prevalence of HBV infection is observed in HBsAg–
negative HCC in Japanese population.(63) 
So HBV role in the pathogenesis of HCC is underestimated in our 
study. Together with the fact that some patients (n=10) were diagnosed as 
HCC based on liver biopsy and high AFP levels (400ng/dl) were excluded 
from our study population. Nine out of the ten were positive for the antigen. 
Mother to child transmission was studied in Juba, south of Sudan, it 
was found that 55.5% of HBs-Ag positive mothers had children with positive 
serology whereas 11.4% of negative HBs-Ag mothers had positive children 
for the virus (11.4%) n=88. (18) 
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The southern region shows a high risk area of vertical transmission of 
HBV of 55% but in contradiction a much lower incidence of HCC compared 
to other regions. (18) 
In Saudi Arabia, HBs-Ag was positive in 65% of HCC cases.(10) In 
Nigeria the estimated rate in1970 was 6.6\100,000.(11) The most common 
predisposing factor was HBV. (11) 
The prevalence of HBV infection in adult population of Senegal is up 
to 85%. HBV markers were detected in59.4% of sera of children. This 
explains the high incidence of HCC.(12) In a Mozambique, the prevalence of 
HBV s-Ag in HCC patients was 60% of the studied population (n=328).(13) 
Hepatitis C virus: 
Seroprevalence of HCV was 18.75% in our studied population. 
Incomparable figures were found in Sudan. 
Prevalence of about 2% in the west and 3% in Juba (1994) was 
obtained in the studies where HCV was screened in the population. Increased 
prevalence of HCV compared to the general population is evident in our 
study. 
Epidemiologic studies detected 15-80% of HCC patients harboring 
the virus depending on the area of the study, being higher in Japan, Italy and 
Spain. PCR showed 62% of Spanish patients having HCC were positive for 
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HCV RNA, 20% of South Africans blacks were positive. (8) 
HCV does not seem to be a major problem as HBV in Africa and Sudan.  
Alcohol: 
History of previous alcohol intake was recorded in 47% of our 
patients. Only 12% showed combined infection with HBV, HCV, or both. 
Generally alcohol consumption is a common predisposing factor in 
areas where HBV is rare as in western countries. Alcohol consumption is 
common in Sudan in the form of Marisa and Aragi a form obtained from 
fermented dates and cereals. Marisa is made of stored millet which also can 
carry the risk of aflatoxin contamination. 
HCC due to alcohol is common in Rhodesian blacks. The entire 
studied group (n=28) were negative for HBVs-Ag. 
In USA and Italy, alcoholic cirrhosis is the most predisposing factor 
of HCC, 32% and 45% respectively. Alcohol causes cirrhosis which is a 
predisposing factor to cancer especially the multinodular type. (8) 
All patients who consumed alcohol were cirrhotic. This has proved to 
be a significant relationship (P=0.045). 
Epidemiologic studies describe that alcoholics are at risk of 
developing viral infections.(37)  
 A group (12%) of our studied population was also viral carriers. 
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Alcohol acts synergistically with other risk factors especially HCV, creating a 
worse outcome.(37) 
Only one patient in our studied population harbor viruses, HBV and 
HCV and consuming alcohol. The tumor was extensive with lymph node 
involvement and metastasis to the peritoneal cavity. 
Interaction between HBV and aflatoxin has been shown to induce 
carcinogenesis. This may explain the high incidence in the west. Alcohol also 
is not uncommon. 
The mechanisms involve more injury to liver cells which renders the 
hepatocyte more vulnerable to persistent mutation and oxidative stresses with 
consequent defeated reparative mechanisms.(36,37) 
Cirrhosis: 
About 87% of the patients (n=31) developed HCC on top of 
cirrhosis. This is in concordance with the fact that 80% of HCC patients have 
cirrhosis of the liver. (37, 38) 
In one study in Sudanese HCC patients, 83 % of the studied group 
had irregular surface of the liver while 32% had clinical evidence of 
cirrhosis. (17) 
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Unknown risk factor group: 
We used the term unknown risk factor group to describe the patients 
who did not consume alcohol, neither HBs-Ag or anti HC- antibody was 
positive. Although it is not accurate, since aflatoxin exposure, iron overload, 
metabolic diseases leading to HCC as tyrsinosis, and history of exposure to 
chemicals and pesticides were all not evaluated. 
Eight patients were under such a category. Mean age at presentation 
was delayed to 63 years. Mean age for the whole group was 58.2 years. 
Occupation was known for only 3 of them and unsurprisingly all were 
farmers.  
PCR techniques to detect HBV are needed to certainly confirm its 
absence since negative serologic tests for HBsAg does not indicate absence 
of infection. (17) 
Two patients with no identified risk factor had periportal fibrosis on 
ultrasonography, which indicates past history of schistomoisais. Previous 
studies ruled out any role of schistosoma worms in HCC development. (17) 
Aflatoxins: 
Aflatoxin is a mycotoxin produced by A. flavus which can invade any 
organic matter whenever warm, humid climatic conditions are available. The 
south and the west of Sudan are favorable areas. Peanuts are especially 
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contaminated and it is grown mainly in the west. This may partly explain the 
high incidence of HCC in Darfur and Kordofan. 
Aflatoxin M1 and M2 are major metabolites of aflatoxin B1 and B2 
respectively. They are found in milk of animals who have consumed feed 
contaminated by the fungus. Aflatoxin should not be attributed to grain 
contamination alone but also to drinking of raw milk. 
Increased incidence of HCC is reported in countries with increased 
aflatoxin intake.(40)Aflatoxins act synergistically with HBV to modify the risk 
of HCC development. This is manifested by causing mutation of the P53 
gene at codon 249- third base and takes the form of G to T transversion.(2, 40) 
Epidemiologic studies showed that the incidence of P53 mutation is 
quite high in Mozambique and China (50%) where aflatoxin is a common 
contaminant. In countries which do not consume contaminated food (Europe 
and the USA), the rate of P53 mutations in HCC is low.(39,40)Epidemiologic 
studies in Sudan should be carried out to define the extent of exposure risk. 
Aflatoxin has been demonstrated in human cord blood and sera of 
women immediately after birth.(40) These observations stresses more on the 
carcinogenic and mutagenic potential of aflatoxin being played early in life. 
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Other illnesses: 
Five patients in the studied HCC population were diabetic, on oral 
hypoglycemic (glebenclamide), six patients had past history of either urinary 
or intestinal shistosomiasis or both. However periportal fibrosis was 
demonstrated in two patients only. Two were hypertensive and only one 
patient had gross obesity.  
Epidemiologic studies have shown that obesity and diabetes mellitus 
are risk factors for HCC. Case reports have shown progression of NAFL to 
cirrhosis. (42) 
In one study in Texas, the authors concluded that there is synergy 
between heavy alcohol consumption and chronic viral hepatitis and diabetes 
mellitus independent of each other in the etiology of HCC. (45) 
In the USA, the risk factors were analyzed in 105 HCC patients. 
HCV accounted for 51%, and cryptogenic cirrhosis 29%. Half of the patients 
with cryptogenic cirrhosis had histological or clinical features associated with 
non alcoholic fatty liver disease. They concluded that NAFL disease may be 
the underlying cause for HCC. (43) HCC will develop in up to 30% of patients 
with hereditary haemochromatosis. (8, 25) 
The risk of dietary iron overload was 4.1 in black Africans which is 
similar to that of haemochromatosis in Caucasians.(29) 
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The use of iron pots for cooking is common in Sudan. More 
elaboration is needed in this topic. 
Tumor size and Morphology: 
Macroscopic features of HCC vary depending on the tumor size and 
the presence or absence of cirrhosis. (1, 21)   The majority of the tumors were 
solitary (56.7%), nodular (36.6%) and the least gross appearance was diffuse 
form (6.7%). Diffuse pattern is mentioned in literature as an uncommon 
form. 
Patients with underlying cirrhosis (n=19) presented with either a 
solitary mass (n=10) or nodular (n=7) growth forms. WHO stated that most 
of cirrhotic livers will develop solitary masses with satellite nodules.(1) No 
patient presented with a tumor size of less than 5cm in diameter. This 
indicates late presentation and poorer prognosis. 
Alfa fetoprotein (AFP): 
Alfa fetoprotein is useful as a tumor marker in screening and 
diagnosis of HCC. Elevated values of more than 10 ng/dl were observed in 
67% of the patients found tested for it. Only 29 %( n=21) had values above 
400 ng/dl. AFP level of 400ng/dl or above was used together with the 
presence of a liver mass to diagnose HCC. This avoids the invasion's nature 
of liver biopsy. (1,58) 
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This trend has been adopted in ISH. Some patients were diagnosed 
by demonstrating a liver mass, AFP >400 ng/dl and positive serology for 
either HBV or HCV. 
About 10 patients were found diagnosed by this criterion during our 
study period. All were having very high AFP levels more than 400 ng/dl. If 
they are included with our study population (n=31), high AFP level will be 
found in 16/31 patients (49%). 
Mohammedian found that 74% of HCC patients had levels >10 ng/dl 
and 51% had values above 400 ng/dl.(17) 
Among the patients screened in his study, including other liver 
diseases levels above 400 ng/dl were found only in HCC patients except 3 
patients with advanced liver cirrhosis, all HBV positive and had high PIVKA 
II values. So he concluded that a level of 400 ng can be used to differentiate 
HCC from other liver diseases. 
Nine patients were HBVs-Ag positive and only one infected with 
HCV. Five were from the west, mean age was 54.2 years and M: F=9:1. We 
notice that the results are comparable to the previous results. Taking these 
findings in consideration, avoidance of liver biopsy in such critically ill 
patients is recommended.  
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CONCLUSION 
• A total of 63 HCC patients diagnosed at Ibn Sina hospital in the 
period 2003- 2004 inclusive were studied. 
• The mean age at presentation was 58.2 years and males dominated 
females.  Half of the patients were from the western region.  
• The majority were farmers and labors. 
• -Most of the patients presented late with no patient being diagnosed 
with a small tumor size of. Those with tumor size of more than 10 
cm were the majority. Solitary and nodular morphological types 
were the commonest types encountered in imaging. 
• Compact pattern constituted 42%, followed by the trabecular 
pattern.  Clear cell variant was seen in 24% of the sections. Half of 
the specimens were of poor differentiation. 
• Hepatitis B virus was positive in 41% of patients screened for it; 
HCV in 19% and 47% consumed alcohol. 
• Cirrhosis was underlying 87 % of cases whose cirrhotic state was 
mentioned. 
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RECOMMENDATIONS 
• Introduction of vaccination for hepatitis B in infancy and among 
high risk groups.  
• Parameters for prevention of hepatitis C virus infection should be 
nationally implemented through screening in blood banks and 
following the WHO safe injection global network (SIGN).   
• Patient education about aflatoxin contamination of food and ways 
of proper storage is important. 
• Early detection of HCC by close follow up of risk groups.  
• Genetic and immunological studies should be done so as to clarify 
the vulnerability of some racial groups and resistance of others.  
• Establishment of a common histological criterion will ease 
diagnosing and reporting of HCC tumors. 
• Improvement of medical recording would provide suitable 
material for retrospective studies.  
• Maintenance of cancer registry in Sudan.  
• More scientific elaboration is needed on the avoidance of liver 
biopsy in the diagnosis of HCC patients.  
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• Studying the chemical nature of local alcohol and its effect on 
carcinogensis of HCC. 
• Field experimental work need to done to evaluate the hazard of 
iron overload from pots and cans.  
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